|
|
|
Scientific Literature, diabetes
-
Aarnisalo J, Treszl A, Svec P, Marttila J, Oling V, Simell O, Knip M, Korner A, Madacsy L, Vasarhelyi B, Ilonen J, Hermann R 2008 Reduced CD4(+)T cell activation in children with type 1 diabetes carrying the PTPN22/Lyp 620Trp variant.
J. Autoimmun. 31: 13-21.
-
Aarnisalo J, Veijola R, Vainionpaa R, Simell O, Knip M, Ilonen J 2008 Cytomegalovirus infection in early infancy: risk of induction and progression of autoimmunity associated with type 1 diabetes.
Diabetologia 51: 769-772.
*
-
Abahusain MA, Al-Nahedh NN 2002 The biochemical status of vitamin A and alpha-tocopherol during different stages of renal disease and its relationship to diabetes.
Saudi J. Kidney Dis. Transpl. 13: 18-23.
-
Abate N, Chandalia M, Di Paola R, Foster DW, Grundy SM, Trischitta V 2006 Mechanisms of disease: ectonucleotide pyrophosphatase phosphodiesterase 1 as a 'gatekeeper' of insulin receptors.
Nat. Clin. Pract. Endocrinol. Metab. 2: 694-701.
*
-
Abate N, Chandalia M, Satija P, Adams-Huet B, Grundy SM, Sandeep S, Radha V, Deepa R, Mohan V 2005 ENPP1/PC-1 K121Q polymorphism and genetic susceptibility to type 2 diabetes.
Diabetes 54: 1207-1213.
*
-
Abbas Z, Jafri W, Rasool S, Abid S, Hameed I 2007 Mucormycosis in patients with complicated cirrhosis.
Singapore Med. J. 48: 69-73.
*
-
Abdel Aziz AM, Lehman GA 2007 Current treatment options for chronic pancreatitis.
Curr. Treat. Options Gastroenterol. 10: 355-368.
-
Abdelmalek M, Ludwig J, Lindor KD 1995 Two cases from the spectrum of nonalcoholic steatohepatitis.
J. Clin. Gastroenterol. 20: 127-130.
-
Abdelmalek MF, Liu C, Shuster J, Nelson DR, Asal NR 2006 Familial aggregation of insulin resistance in first-degree relatives of patients with nonalcoholic fatty liver disease.
Clin. Gastroenterol. Hepatol. 4: 1162-1169.
-
Abderrahmani A, Chevre JC, Otabe S, Chikri M, Hani EH, Vaxillaire M, Hinokio Y, Horikawa Y, Bell GI, Froguel P 2000 Genetic variation in the hepatocyte nuclear factor-3beta gene (HNF3B) does not contribute to maturity-onset diabetes of the young in French Caucasians.
Diabetes 49: 306-308.
*
-
Abdul-Hai A, Hershkoviz R, Weiss L, Lider O, Slavin S 2005 Effect of linomide on adhesion molecules, TNF-alpha, nitrogen oxide, and cell adhesion.
Int. Immunopharmacol. 5: 231-239.
-
Abdullah MA 2005 Epidemiology of type I diabetes mellitus among Arab children.
Saudi Med. J. 26: 911-917.
-
Abe T, Iinuma Y, Ando M, Yokoyama T, Yamamoto T, Nakashima K, Takagi N, Baba H, Hasegawa Y, Shimokata K 2003 NRAMP1 polymorphisms, susceptibility and clinical features of tuberculosis.
J. Infect. 46: 215-220.
-
Abe T, Takino H, Yamasaki H, Ozaki M, Sera Y, Kondo H, Sakamaki H, Kawasaki E, Awata T, Yamaguchi Y, Eguchi K 1999 CTLA4 gene polymorphism correlates with the mode of onset and presence of ICA512 Ab in Japanese type 1 diabetes.
Diabetes Res. Clin. Pract. 46: 169-175.
-
Abebe F, Mustafa T, Nerland AH, Bjune GA 2006 Cytokine profile during latent and slowly progressive primary tuberculosis: a possible role for interleukin-15 in mediating clinical disease.
Clin. Exp. Immunol. 143: 180-192.
*
-
Abiru N, Kawasaki E, Eguch K 2002 Current knowledge of Japanese type 1 diabetic syndrome.
Diabetes Metab. Res. Rev. 18: 357-366.
*
-
Abrahamian H, Endler G, Exner M, Mauler H, Raith M, Endler L, Rumpold H, Gerdov M, Mannhalter C, Prager R, Irsigler K, Wagner OF 2007 Association of low-grade inflammation with nephropathy in type 2 diabetic patients: role of elevated CRP-levels and 2 different gene-polymorphisms of proinflammatory cytokines.
Exp. Clin. Endocrinol. Diabetes 115: 38-41.
-
Abrams GA, Kunde SS, Lazenby AJ, Clements RH 2004 Portal fibrosis and hepatic steatosis in morbidly obese subjects: a spectrum of nonalcoholic fatty liver disease.
Hepatology 40: 475-483.
*
-
Abreu MT, Yang H 2004 Is genetic testing in IBD ready for prime time?
Am. J. Gastroenterol. 99: 316-318.
*
-
Abu-Zekry M, Kryszak D, Diab M, Catassi C, Fasano A 2008 Prevalence of celiac disease in Egyptian children disputes the East-West agriculture-dependent spread of the disease.
J. Pediatr. Gastroenterol. Nutr. 47: 136-140.
-
Acevedo-Suarez CA, Hulbert C, Woodward EJ, Thomas JW 2005 Uncoupling of anergy from developmental arrest in anti-insulin B cells supports the development of autoimmune diabetes.
J. Immunol. 174: 827-833.
*
-
Acha-Orbea H 1991 Limited heterogeneity of autoantigens and T cells in autoimmune diseases?
Res. Immunol. 142: 487-490.
-
Achenbach P, Fuchtenbusch M 2004 Modulating the autoimmune response in type 1 diabetes: a report on the 64th Scientific Sessions of the ADA, June 2004, Orlando, FL, USA.
Rev. Diabet. Stud. 1: 137-140.
*
-
Adam SJ, Counter CM 2008 A method to generate genetically defined tumors in pigs.
Methods Enzymol. 439: 39-51.
-
Adamiec J, Oficjalska-Mlynczak J 2007 Contribution of selected cellular adhesion molecules and proinflammatory cytokines in the pathogenesis of proliferative diabetic retinopathy.
Przegl. Lek. 64: 389-392.
-
Adamiec R, Gacka M, Dobosz T, Szymaniec S, Bednarska-Chabowska D, Sadakierska-Chudy A 2007 Stimulation of the peroxisome proliferator-activated receptor gamma (PPARgamma) and the expression of selected blood monocyte cytokine genes in diabetic macroangiopathy.
Atherosclerosis 194: e108-e115.
-
Adamiec-Mroczek J, Oficjalska-Mlynczak J 2008 Assessment of selected adhesion molecule and proinflammatory cytokine levels in the vitreous body of patients with type 2 diabetes - role of the inflammatory-immune process in the pathogenesis of proliferative diabetic retinopathy.
Graefes Arch. Clin. Exp. Ophthalmol. Aug 6 [Epub ahead of print].
*
-
Adams LA, Feldstein A, Lindor KD, Angulo P 2004 Nonalcoholic fatty liver disease among patients with hypothalamic and pituitary dysfunction.
Hepatology 39: 909-914.
*
-
Adams PC 2000 Nonexpressing homozygotes for C282Y hemochromatosis: minority or majority of cases?
Mol. Genet. Metab. 71: 81-86.
*
-
Adamson KA, Cheetham TD, Kendall-Taylor P, Seckl JR, Pearce SH 2007 The role of the IDDM2 locus in the susceptibility of UK APS1 subjects to type 1 diabetes mellitus.
Int. J. Immunogenet. 34: 17-21.
*
-
Addous A, Mohamed AS, Ismail G, Al-Hashemy A 2000 Post-transplant diabetes mellitus in kidney transplant recipients with special reference to association with HLA antigens.
Saudi J. Kidney Dis. Transpl. 11: 559-562.
-
Adibi SA 2003 Regulation of expression of the intestinal oligopeptide transporter (Pept-1) in health and disease.
Am. J. Physiol. Gastrointest. Liver Physiol. 285: G779-G788.
*
-
Adiels M, Taskinen MR, Packard C, Caslake MJ, Soro-Paavonen A, Westerbacka J, Vehkavaara S, Hakkinen A, Olofsson SO, Yki-Jarvinen H, Boren J 2006 Overproduction of large VLDL particles is driven by increased liver fat content in man.
Diabetologia 49: 755-765.
*
-
Adler AI, Gunn E, Haworth CS, Bilton D 2007 Characteristics of adults with and without cystic fibrosis-related diabetes.
Diabet. Med. 24: 1143-1148.
*
-
Adler AI, Shine BS, Chamnan P, Haworth CS, Bilton D 2008 Genetic determinants and epidemiology of cystic fibrosis-related diabetes - results from a British cohort of children and adults.
Diabetes Care 31: 1789-1794.
-
Adorini L 2000 New trends in clinical and experimental immunosuppression - fourth international conference.
IDrugs 3: 496-498.
-
Adorini L, Penna G 2008 Control of autoimmune diseases by the vitamin D endocrine system.
Nat. Clin. Pract. Rheumatol. 4: 404-412.
-
Agalliu I, Suuriniemi M, Prokunina-Olsson L, Johanneson B, Collins FS, Stanford JL, Ostrander EA 2008 Evaluation of a variant in the transcription factor 7-like 2 (TCF7L2) gene and prostate cancer risk in a population-based study.
Prostate 68: 740-747.
-
Aganna E, Aksentijevich I, Hitman GA, Kastner DL, Hoepelman AI, Posma FD, Zweers EJ, McDermott MF 2001 Tumor necrosis factor receptor-associated periodic syndrome (TRAPS) in a Dutch family: evidence for a TNFRSF1A mutation with reduced penetrance.
Eur. J. Hum. Genet. 9: 63-66.
*
-
Aganna E, Hawkins PN, Ozen S, Pettersson T, Bybee A, McKee SA, Lachmann HJ, Karenko L, Ranki A, Bakkaloglu A, Besbas N, Topaloglu R, Hoffman HM, Hitman GA, Woo P, McDermott MF 2004 Allelic variants in genes associated with hereditary periodic fever syndromes as susceptibility factors for reactive systemic AA amyloidosis.
Genes Immun. 5: 289-293.
*
-
Agardh D 2007 Antibodies against synthetic deamidated gliadin peptides and tissue transglutaminase for the identification of childhood celiac disease.
Clin. Gastroenterol. Hepatol. 5: 1276-1281.
-
Agardh D, Lynch K, Brundin C, Ivarsson SA, Lernmark A, Cilio CM 2006 Reduction of tissue transglutaminase autoantibody levels by gluten-free diet is associated with changes in subsets of peripheral blood lymphocytes in children with newly diagnosed coeliac disease.
Clin. Exp. Immunol. 144: 67-75.
*
-
Agarwal K, Jones DE, Daly AK, James OF, Vaidya B, Pearce S, Bassendine MF 2000 CTLA-4 gene polymorphism confers susceptibility to primary biliary cirrhosis.
J. Hepatol. 32: 538-541.
*
-
Agarwal N, Sharma BC 2005 Insulin resistance and clinical aspects of non-alcoholic steatohepatitis (NASH).
Hepatol. Res. 33: 92-96.
-
Aggarwal BB 2003 Signalling pathways of the TNF superfamily: a double-edged sword.
Nat. Rev. Immunol. 3: 745-756.
*
-
Aggarwal BB, Shishodia S 2004 Suppression of the nuclear factor-kappaB activation pathway by spice-derived phytochemicals: reasoning for seasoning.
Ann. N. Y. Acad. Sci. 1030: 434-441.
-
Aggarwal BB, Shishodia S, Sandur SK, Pandey MK, Sethi G 2006 Inflammation and cancer: how hot is the link?
Biochem. Pharmacol. 72: 1605-1621.
*
-
Aggarwal BB, Shishodia S, Takada Y, Jackson-Bernitsas D, Ahn KS, Sethi G, Ichikawa H 2006 TNF blockade: an inflammatory issue.
Ernst Schering Res. Found. Workshop 56: 161-186.
-
Agostoni C, Decsi T, Fewtrell M, Goulet O, Kolacek S, Koletzko B, Michaelsen KF, Moreno L, Puntis J, Rigo J, Shamir R, Szajewska H, Turck D, van Goudoever J; ESPGHAN Committee on Nutrition: 2008 Complementary feeding: a commentary by the ESPGHAN Committee on Nutrition.
J. Pediatr. Gastroenterol. Nutr. 46: 99-110.
-
Agostoni C, Shamir R 2008 For debate: can a change in policy of complementary infant feeding reduce the risk for type 1 diabetes and celiac disease?
Pediatr. Endocrinol. Rev. 6: 2-4.
-
Agrawal RP, Rathore A, Joshi A, Changal H, Kochar DK 2008 Prevalence of celiac disease in type 1 diabetes mellitus in North West Rajasthan, India.
Diabetes Res. Clin. Pract. 79: e15-e16.
-
Agrawal S, Dimitrova N, Prasthani N, Udayakumar K, Sailakshmi S, Sriram S, Manjusha N, Sengupta U 2008 T2D-Db: an integrated platform to study the molecular basis of type 2 diabetes.
BMC Genomics 9: 320.
*
-
Agte VV, Tarwadi KV 2008 Combination of diabetes and cataract worsens the oxidative stress and micronutrient status in Indians.
Nutrition 24: 617-624.
-
Aguirre AL, Center SA, Randolph JF, Yeager AE, Keegan AM, Harvey HJ, Erb HN 2007 Gallbladder disease in Shetland sheepdogs: 38 cases (1995-2005).
J. Am. Vet. Med. Assoc. 231: 79-88.
-
Ahluwalia TS, Ahuja M, Rai TS, Kohli HS, Sud K, Bhansali A, Khullar M 2008 Endothelial nitric oxide synthase gene haplotypes and diabetic nephropathy among Asian Indians.
Mol. Cell. Biochem. 314: 9-17.
*
-
Ahmed I, Furlong K, Flood J, Treat VP, Goldstein BJ 2007 Dual PPAR alpha/gamma agonists: promises and pitfalls in type 2 diabetes.
Am. J. Ther. 14: 49-62.
-
Ahmed I, Nasreen S, Bhatti R 2007 Alopecia areata in children.
J. Coll. Physicians Surg. Pak. 17: 587-590.
-
Ahmed S, Ihara K, Bassuny WM, Kuromaru R, Kohno H, Miyako K, Matsuura N, Iwata I, Nagafuchi S, Hara T 2002 Association study between CD30 and CD30 ligand genes and type 1 diabetes in the Japanese population.
Genes Immun. 3: 96-101.
*
-
Ahmed W, Ziouzenkova O, Brown J, Devchand P, Francis S, Kadakia M, Kanda T, Orasanu G, Sharlach M, Zandbergen F, Plutzky J 2007 PPARs and their metabolic modulation: new mechanisms for transcriptional regulation?
J. Intern. Med. 262: 184-198.
*
-
Ahn JH, Shin MS, Jung SH, Kang SK, Kim KR, Rhee SD, Jung WH, Yang SD, Kim SJ, Woo JR, Lee JH, Cheon HG, Kim SS 2006 Indenone derivatives: a novel template for peroxisome proliferator-activated receptor gamma (PPARgamma) agonists.
J. Med. Chem. 49: 4781-4784.
*
-
Ahn KS, Aggarwal BB 2005 Transcription factor NF-kappaB: a sensor for smoke and stress signals.
Ann. N. Y. Acad. Sci. 1056: 218-233.
*
-
Ahrens ET, Morel PA 2005 In vivo imaging of autoimmune disease in model systems.
Curr. Top. Dev. Biol. 70C: 215-238.
-
Ahuja HS, Szanto A, Nagy L, Davies PJ 2003 The retinoid X receptor and its ligands: versatile regulators of metabolic function, cell differentiation and cell death.
J. Biol. Regul. Homeost. Agents 17: 29-45.
-
Airaghi L, Tedeschi A 2006 Negative association between occurrence of type 1 diabetes and tuberculosis incidence at population level.
Acta Diabetol. 43: 43-45.
*
-
Aithal GP 2007 Dangerous liaisons: drug, host and the environment.
J. Hepatol. 46: 995-998.
*
-
Aittoniemi J, Turpeinen H, Tiittanen M, Knip M, Simell O, Ilonen J, Vaarala O 2008 Relation among mannose-binding lectin 2 genotype, beta-cell autoantibodies, and risk for type 1 diabetes in Finnish children.
Hum. Immunol. 69: 108-111.
-
Ajuebor MN, Aspinall AI, Zhou F, Le T, Yang Y, Urbanski SJ, Sidobre S, Kronenberg M, Hogaboam CM, Swain MG 2005 Lack of chemokine receptor CCR5 promotes murine fulminant liver failure by preventing the apoptosis of activated CD1d-restricted NKT cells.
J. Immunol. 174: 8027-8037.
*
-
Ajuebor MN, Carey JA, Swain MG 2006 CCR5 in T cell-mediated liver diseases: what's going on?
J. Immunol. 177: 2039-2045.
*
-
Akerblom HK, Vaarala O, Hyoty H, Ilonen J, Knip M 2002 Environmental factors in the etiology of type 1 diabetes.
Am. J. Med. Genet. 115: 18-29.
-
Akesson L, Gelling RW, Jensen R, Ogimoto K, Fuller JM, Pefley R, Manavi S, Lernmark A, Schwartz MW 2008 Increased lipid oxidation heralds diabetes onset in DR.lyp/lyp rats.
Exp. Clin. Endocrinol. Diabetes 116: 475-480.
-
Akimoto T, Kobayashi S, Tamura N, Ohsawa T, Kawano T, Tanaka M, Hashimoto H 2005 Risk factors for recurrent thrombosis: prospective study of a cohort of Japanese systemic lupus erythematosus.
Angiology 56: 601-609.
-
Akinci A, Cetinkaya E, Aycan Z 2007 Dry eye syndrome in diabetic children.
Eur. J. Ophthalmol. 17: 873-878.
-
Akinci B, Comlekci A, Tankurt E 2008 Hypercalcemia of primary hyperparathyroidism was treated by cinacalcet in a patient with liver cirrhosis.
Exp. Clin. Endocrinol. Diabetes Jun 17 [Epub ahead of print].
-
Aksoy DY, Agbaht K, Harmanci O, Karadag O, Aytemir K, Sungur A, Onat AM, Apras S, Yildiz BO, Bayraktar M 2008 Autoimmune polyendocrine syndrome with atrial septal defect.
Am. J. Med. Sci. 335: 157-159.
-
Al-Daghri NM, Al-Attas OS, Al-Rubeaan K, Sallam R 2008 Adipocytokine profile of type 2 diabetics in metabolic syndrome as defined by various criteria.
Diabetes Metab. Res. Rev. 24: 52-58.
-
Al-Harbi EM, Abbassi AJ, Tamim H, al-Jenaidi F, Kooheji M, Kamal M, al-Mahroos S, al-Nasir F, Motala AA, Almawi WY 2004 Specific HLA-DRB and -DQB alleles and haplotypes confer disease susceptibility or resistance in Bahraini type 1 diabetes patients.
Clin. Diagn. Lab. Immunol. 11: 292-296.
*
-
Al-Jenaidi FA, Wakim-Ghorayeb SF, Al-Abbasi A, Arekat MR, Irani-Hakime N, Najm P, Al-Ola K, Motala AA, Almawi WY 2005 Contribution of selective HLA-DRB1/DQB1 alleles and haplotypes to the genetic susceptibility of type 1 diabetes among Lebanese and Bahraini Arabs.
J. Clin. Endocrinol. Metab. 90: 5104-5109.
*
-
Al-Kateb H, Mirea L, Xie X, Sun L, Liu M, Chen H, Bull SB, Boright AP, Paterson AD 2007 Multiple variants in vascular endothelial growth factor (VEGF) are risk factors for time to severe retinopathy in type 1 diabetes: the DCCT/EDIC genetics study.
Diabetes 56: 2161-2168.
*
-
Alam MA, Husain SA, Narang R, Chauhan SS, Kabra M, Vasisht S 2008 Association of polymorphism in the thermolabile 5,10-methylene tetrahydrofolate reductase gene and hyperhomocysteinemia with coronary artery disease.
Mol. Cell. Biochem. 310: 111-117.
-
Alard P, Manirarora JN, Parnell SA, Hudkins JL, Clark SL, Kosiewicz MM 2006 Deficiency in NOD antigen-presenting cell function may be responsible for suboptimal CD4+CD25+ T-cell-mediated regulation and type 1 diabetes development in NOD mice.
Diabetes 55: 2098-2105.
*
-
Alaynick WA 2008 Nuclear receptors, mitochondria and lipid metabolism.
Mitochondrion Feb 26 [Epub ahead of print].
-
Alba A, Planas R, Clemente X, Carrillo J, Ampudia R, Puertas MC, Pastor X, Tolosa E, Pujol-Borrell R, Verdaguer J, Vives-Pi M 2008 Natural killer cells are required for accelerated type 1 diabetes driven by interferon-beta.
Clin. Exp. Immunol. 151: 467-475.
*
-
Alba LM, Lindor K 2003 Review article: non-alcoholic fatty liver disease.
Aliment. Pharmacol. Ther. 17: 977-986.
*
-
Albahrani AI, Usher J, Marks E, Ranganath L, Shenkin A 2007 Atypical presentation of a middle age male with severe hypertriglyceridaemia: a case report.
J. Med. Case Reports 1: 51.
*
-
Albala BC, Jimenez RB, Perez B F, Liberman GC 2006 Fatty acid binding protein 2 (FABP-2) polymorphism, obesity and insulin resistance.
Rev. Med. Chil. 134: 372-379.
-
Albala C, Villarroel A, Santos JL, Angel B, Lera L, Liberman C, Sanchez H, Perez-Bravo F 2007 FABP2 Ala54Thr polymorphism and diabetes in Chilean elders.
Diabetes Res. Clin. Pract. 77: 245-250.
-
Albano E, Mottaran E, Vidali M, Reale E, Saksena S, Occhino G, Burt AD, Day CP 2005 Immune response towards lipid peroxidation products as a predictor of progression of non-alcoholic fatty liver disease to advanced fibrosis.
Gut 54: 987-993.
*
-
Alberti-Flor JJ, Jeffers L, Schiff ER 1984 Primary sclerosing cholangitis occurring in a patient with systemic lupus erythematosus and diabetes mellitus.
Am. J. Gastroenterol. 79: 889-891.
-
Alemany-Rodriguez MJ, Aladro Y, Amela-Peris R, Perez-Vieitez MC, Reyes-Yanez MP, Deniz-Naranjo MC, Sanchez-Garcia F 2005 Autoimmune diseases and multiple sclerosis.
Rev. Neurol. 40: 594-597.
-
Alenghat T, Yu J, Lazar MA 2006 The N-CoR complex enables chromatin remodeler SNF2H to enhance repression by thyroid hormone receptor.
EMBO J. 25: 3966-3974.
*
-
Alexander E, Pinto J, Pal GS, Kamath N, Kuruvilla M 2001 Disease concomitance in psoriasis: a clinical study of 61 cases.
Indian J. Dermatol. Venereol. Leprol. 67: 66-68.
-
Alison MR, Choong C, Lim S 2007 Application of liver stem cells for cell therapy.
Semin. Cell Dev. Biol. 18: 819-826.
*
-
Alizadeh BZ, Valdigem G, Coenen MJ, Zhernakova A, Franke B, Monsuur A, van Riel PL, Barrera P, Radstake TR, Roep BO, Wijmenga C, Koeleman BP 2007 Association analysis of functional variants of the FcgRIIa and FcgRIIIa genes with type 1 diabetes, celiac disease and rheumatoid arthritis.
Hum. Mol. Genet. 16: 2552-2559.
-
Allcock RJ, Christiansen FT, Price P 1999 The central MHC gene IKBL carries a structural polymorphism that is associated with HLA-A3,B7,DR15.
Immunogenetics 49: 660-665.
*
-
Allen DB, MacDonald MJ, Gottschall JL, Hunter JB 1989 Autoimmune thyroid phenomena are not evidence for human lymphocyte antigen-genetic heterogeneity in insulin-dependent diabetes.
Am. J. Med. Genet. 33: 405-408.
-
Allen T, Zhang F, Moodie SA, Clemens LE, Smith A, Gregoire F, Bell A, Muscat GE, Gustafson TA 2006 Halofenate is a selective peroxisome proliferator-activated receptor gamma modulator with antidiabetic activity.
Diabetes 55: 2523-2533.
*
-
Allgayer H, Kruis W 2003 PPAR-ligands: a clinically important regulatory system with multiple options in the treatment of diabetes mellitus, inflammatory bowel disease and in the chemoprevention of colon cancer?
Z. Gastroenterol. 41: 1035-1038.
-
Allotey RA, Mohan V, McDermott MF, Deepa R, Premalatha G, Hassan Z, Cassell PG, North BV, Vaxillaire M, Mein CA, Swan DC, O'Grady E, Ramachandran A, Snehalatha C, Sinnot PJ, Hemmatpour SK, Froguel P, Hitman GA 2004 The EIF2AK3 gene region and type I diabetes in subjects from South India.
Genes Immun. 5: 648-652.
*
-
Alnajjar A, Chabane Sari D, Abuharfeil N, Hudaib M, Aburjai T 2006 Effect of n-3 and n-6 polyunsaturated fatty acids on lymphocyte proliferation, interleukin production and phospholipid fatty acids composition in type 2 diabetic and healthy subjects in Jordan people.
Prostaglandins Leukot. Essent. Fatty Acids 74: 347-356.
*
-
Alnounou M, Munoz SJ 2006 Nutrition Issues In Gastroenterology, Series #37. Nutrition concerns of the patient with primary biliary cirrhosis or primary sclerosing cholangitis. [http://www.healthsystem.virginia.edu/internet/digestive-health/nutritionarticles/April2006.pdf]
Practical Gastroenterology April 2006: 92-100. *
-
Alonso N, Granada ML, Salinas I, Reverter JL, Flores L, Ojanguren I, Martinez-Caceres EM, Sanmarti A 2007 Plasma ghrelin concentrations in type 1 diabetic patients with autoimmune atrophic gastritis.
Eur. J. Endocrinol. 157: 763-769.
*
-
Alper CA, Husain Z, Larsen CE, Dubey DP, Stein R, Day C, Baker A, Beyan H, Hawa M, Ola TO, Leslie RD 2006 Incomplete penetrance of susceptibility genes for MHC-determined immunoglobulin deficiencies in monozygotic twins discordant for type 1 diabetes.
J. Autoimmun. 27: 89-95.
*
-
Alsaadi G, Quirynen M, Komarek A, van Steenberghe D 2008 Impact of local and systemic factors on the incidence of late oral implant loss.
Clin. Oral Implants Res. 19: 670-676.
-
Alsaadi G, Quirynen M, Komarek A, van Steenberghe D 2007 Impact of local and systemic factors on the incidence of oral implant failures, up to abutment connection.
J. Clin. Periodontol. 34: 610-617.
-
Alsaadi G, Quirynen M, Michiles K, Teughels W, Komarek A, van Steenberghe D 2008 Impact of local and systemic factors on the incidence of failures up to abutment connection with modified surface oral implants.
J. Clin. Periodontol. 35: 51-57.
-
Alsmadi O, Al-Rubeaan K, Wakil SM, Imtiaz F, Mohamed G, Al-Saud H, Al-Saud NA, Aldaghri N, Mohammad S, Meyer BF 2008 Genetic Study of Saudi Diabetes (GSSD): significant association of the KCNJ11 E23K polymorphism with type 2 diabetes.
Diabetes Metab. Res. Rev. 24: 137-140.
-
Altobelli E, Maccarone M, Petrocelli R, Marziliano C, Giannetti A, Peris K, Chimenti S 2007 Analysis of health care and actual needs of patients with psoriasis: a survey on the Italian population.
BMC Public Health 7: 59.
*
-
Altucci L, Leibowitz MD, Ogilvie KM, de Lera AR, Gronemeyer H 2007 RAR and RXR modulation in cancer and metabolic disease.
Nat. Rev. Drug Discov. 6: 793-810.
*
-
Alver A, Mentese A, Karahan SC, Erem C, Keha EE, Arikan MK, Eminagaoglu MS, Deger O 2007 Increased serum anti-carbonic anhydrase II antibodies in patients with Graves' disease.
Exp. Clin. Endocrinol. Diabetes 115: 287-291.
-
Alves Cde A, Aguiar RA, Alves AC, Santana MA 2007 Diabetes mellitus in patients with cystic fibrosis.
J. Bras. Pneumol. 33: 213-221.
*
-
Aly T, Devendra D, Eisenbarth GS 2005 Immunotherapeutic approaches to prevent, ameliorate, and cure type 1 diabetes.
Am. J. Ther. 12: 481-490.
-
Aly TA, Baschal EE, Jahromi MM, Fernando MS, Babu SR, Fingerlin TE, Kretowski A, Erlich HA, Fain PR, Rewers MJ, Eisenbarth GS 2008 Analysis of single nucleotide polymorphisms identifies major type 1A diabetes locus telomeric of the major histocompatibility complex.
Diabetes 57: 770-776.
-
Aly TA, Eller E, Ide A, Gowan K, Babu SR, Erlich HA, Rewers MJ, Eisenbarth GS, Fain PR 2006 Multi-SNP analysis of MHC region: remarkable conservation of HLA-A1-B8-DR3 haplotype.
Diabetes 55: 1265-1269.
*
-
Aly TA, Ide A, Humphrey K, Barker JM, Steck A, Erlich HA, Yu L, Miao D, Redondo MJ, McFann K, Roberts CM, Babu SR, Norris JM, Eisenbarth GS, Rewers MJ 2005 Genetic prediction of autoimmunity: initial oligogenic prediction of anti-islet autoimmunity amongst DR3/DR4-DQ8 relatives of patients with type 1A diabetes.
J. Autoimmun. 25: S40-S45.
-
Aly TA, Ide A, Jahromi MM, Barker JM, Fernando MS, Babu SR, Yu L, Miao D, Erlich HA, Fain PR, Barriga KJ, Norris JM, Rewers MJ, Eisenbarth GS 2006 Extreme genetic risk for type 1A diabetes.
Proc. Natl. Acad. Sci. U.S.A. 103: 14074-14079.
*
-
Amarapurka DN, Amarapurkar AD, Patel ND, Agal S, Baigal R, Gupte P, Pramanik S 2006 Nonalcoholic steatohepatitis (NASH) with diabetes: predictors of liver fibrosis.
Ann. Hepatol. 5: 30-33.
*
-
Amarapurkar A, Ghansar T 2007 Fatty liver: experience from western India.
Ann. Hepatol. 6: 37-40.
*
-
Amarapurkar D, Kamani P, Patel N, Gupte P, Kumar P, Agal S, Baijal R, Lala S, Chaudhary D, Deshpande A 2007 Prevalence of non-alcoholic fatty liver disease: population based study.
Ann. Hepatol. 6: 161-163.
*
-
Amarapurkar DN, Patel ND 2004 Clinical spectrum and natural history of non-alcoholic steatohepatitis with normal alanine aminotransferase values.
Trop. Gastroenterol. 25: 130-134.
-
Amarapurkar DN, Patel ND, Kamani PM 2008 Impact of diabetes mellitus on outcome of HCC.
Ann. Hepatol. 7: 148-151.
*
-
Ambye L, Rasmussen S, Fenger M, Jorgensen T, Borch-Johnsen K, Madsbad S, Urhammer SA 2005 Studies of the Gly482Ser polymorphism of the peroxisome proliferator-activated receptor gamma coactivator 1alpha (PGC-1alpha) gene in Danish subjects with the metabolic syndrome.
Diabetes Res. Clin. Pract. 67: 175-179.
-
Amerio P, Tracanna M, De Remigis P, Betterle C, Vianale L, Marra ME, Di Rollo D, Capizzi R, Feliciani C, Tulli A 2006 Vitiligo associated with other autoimmune diseases: polyglandular autoimmune syndrome types 3B+C and 4.
Clin. Exp. Dermatol. 31: 746-749.
*
-
Aminkeng F, Van Autreve JE, Koeleman BP, Quartier E, Van Schravendijk C, Gorus FK, Van der Auwera BJ; Belgian Diabetes Registry 2007 TNFa microsatellite polymorphism modulates the risk of type 1 diabetes in the Belgian population, independent of HLA-DQ.
Hum. Immunol. 68: 690-697.
-
Amirshahrokhi K, Dehpour AR, Hadjati J, Sotoudeh M, Ghazi-Khansari M 2008 Methadone ameliorates multiple-low-dose streptozotocin-induced type 1 diabetes in mice.
Toxicol. Appl. Pharmacol. Jul 11 [Epub ahead of print].
*
-
Ammann R 2006 Diagnosis and management of chronic pancreatitis: current knowledge.
Swiss Med. Wkly. 136: 166-174.
*
-
Anand P, Kunnumakkara AB, Newman RA, Aggarwal BB 2007 Bioavailability of curcumin: problems and promises.
Mol. Pharm. 4: 807-818.
*
-
Anaya JM, Castiblanco J, Tobon GJ, Garcia J, Abad V, Cuervo H, Velasquez A, Angel ID, Vega P, Arango A 2006 Familial clustering of autoimmune diseases in patients with type 1 diabetes mellitus.
J. Autoimmun. 26: 208-214.
-
Anaya JM, Gomez L, Castiblanco J 2006 Is there a common genetic basis for autoimmune diseases?
Clin. Dev. Immunol. 13: 185-195.
*
-
Andersen G, Burgdorf KS, Sparso T, Borch-Johnsen K, Jorgensen T, Hansen T, Pedersen O 2008 AHSG tagSNPs associate with type 2 diabetes and dyslipidemia: studies of metabolic traits in 7,683 Danish whites.
Diabetes 57: 1427-1432.
-
Andersen G, Overgaard J, Albrechtsen A, Glumer C, Borch-Johnsen K, Jorgensen T, Hansen T, Pedersen O 2006 Studies of the association of the GNB3 825C>T polymorphism with components of the metabolic syndrome in white Danes.
Diabetologia 49: 75-82.
*
-
Andersen HU, Lanng S, Pressler T, Laugesen CS, Mathiesen ER 2006 Cystic fibrosis-related diabetes: the presence of microvascular diabetes complications.
Diabetes Care 29: 2660-2663.
-
Andersen JN, Jansen PG, Echwald SM, Mortensen OH, Fukada T, Del Vecchio R, Tonks NK, Moller NP 2004 A genomic perspective on protein tyrosine phosphatases: gene structure, pseudogenes, and genetic disease linkage.
FASEB J. 18: 8-30.
*
-
Andersen K, Pedersen BK 2008 The role of inflammation in vascular insulin resistance with focus on IL-6.
Horm. Metab. Res. 40: 635-639.
-
Anderson DE 2007 TIM-3 as a therapeutic target in human inflammatory diseases.
Expert Opin. Ther. Targets 11: 1005-1009.
-
Anderson MS, Bluestone JA 2005 The NOD mouse: a model of immune dysregulation.
Annu. Rev. Immunol. 23: 447-485.
*
-
Anderson MS, Venanzi ES, Chen Z, Berzins SP, Benoist C, Mathis D 2005 The cellular mechanism of Aire control of T cell tolerance.
Immunity 23: 227-239.
*
-
Anderson MS, Venanzi ES, Klein L, Chen Z, Berzins SP, Turley SJ, von Boehmer H, Bronson R, Dierich A, Benoist C, Mathis D 2002 Projection of an immunological self shadow within the thymus by the aire protein.
Science 298: 1395-1401.
*
-
Anderson RP 2005 Coeliac disease.
Aust. Fam. Physician 34: 239-242.
-
Andersson G, Svensson AC, Setterblad N, Rask L 1998 Retroelements in the human MHC class II region.
Trends Genet. 14: 109-114.
*
-
Andreeva-Gateva P 2003 Peroxisome proliferator activated receptors PPARs: their role in carbohydrate and lipid metabolism.
Ann. Biol. Clin. (Paris) 61: 295-303.
-
Andren-Sandberg A, Hardt PD 2008 Second Second Giessen International Workshop on Interactions of Exocrine and Endocrine Pancreatic Diseases. Castle of Rauischholzhausen of the Justus-Liebig-University, Giessen (Rauischholzhausen), Germany. March 7-8, 2008.
JOP 9: 541-575.
-
Andrulionyte L, Kuulasmaa T, Chiasson JL, Laakso M 2007 Single nucleotide polymorphisms of the peroxisome proliferator-activated receptor-alpha gene (PPARA) influence the conversion from impaired glucose tolerance to type 2 diabetes: the STOP-NIDDM trial.
Diabetes 56: 1181-1186.
*
-
Andrulionyte L, Peltola P, Chiasson JL, Laakso M 2006 Single nucleotide polymorphisms of PPARD in combination with the Gly482Ser substitution of PGC-1A and the Pro12Ala substitution of PPARG2 predict the conversion from impaired glucose tolerance to type 2 diabetes: the STOP-NIDDM trial.
Diabetes 55: 2148-2152.
*
-
Andrulionyte L, Zacharova J, Chiasson JL, Laakso M; for the STOP-NIDDM Study Group 2004 Common polymorphisms of the PPAR-gamma2 (Pro12Ala) and PGC-1alpha (Gly482Ser) genes are associated with the conversion from impaired glucose tolerance to type 2 diabetes in the STOP-NIDDM trial.
Diabetologia 47: 2176-2184.
*
-
Ang DK, Brodnicki TC, Jordan MA, Wilson WE, Silveira P, Gliddon BL, Baxter AG, van Driel IR 2007 Two genetic loci independently confer susceptibility to autoimmune gastritis.
Int. Immunol. 19: 1135-1144.
-
Ange-van Heugten KD, Burns R, Verstegen MW, Jansen WL, Ferket PR, van Heugten E 2007 Evaluation of diabetes determinants in woolly monkeys (Lagothrix lagotricha).
J. Anim. Physiol. Anim. Nutr. (Berl.) 91: 481-491.
*
-
Angel B, Santos JL, Carrasco E, Albala C, Perez-Bravo F 2004 Vitamin D receptor polymorphism and susceptibility to type 1 diabetes in Chilean subjects: a case-parent study.
Eur. J. Epidemiol. 19: 1085-1087.
*
-
Anghel SI, Wahli W 2007 Fat poetry: a kingdom for PPARgamma.
Cell Res. 17: 486-511.
*
-
Angulo P 2002 Use of ursodeoxycholic acid in patients with liver disease.
Curr. Gastroenterol. Rep. 4: 37-44.
-
Angulo P 2003 Current best treatment for non-alcoholic fatty liver disease.
Expert Opin. Pharmacother. 4: 611-623.
-
Angulo P 2003 Non-alcoholic steatohepatitis.
Falk Symposium 137. XII FALK LIVER WEEK 2003 (Part II) In honour of Hans Popper’s 100th Birthday. Liver Diseases: Advances in Treatment and Prevention. Freiburg (Germany). p. 87-88. October 17 - 19. *
-
Angulo P 2002 Treatment of nonalcoholic fatty liver disease.
Ann. Hepatol. 1: 12-19.
*
-
Angulo P, Alba LM, Petrovic LM, Adams LA, Lindor KD, Jensen MD 2004 Leptin, insulin resistance, and liver fibrosis in human nonalcoholic fatty liver disease.
J. Hepatol. 41: 943-949.
*
-
Angulo P, Keach JC, Batts KP, Lindor KD 1999 Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis.
Hepatology 30: 1356-1362.
*
-
Angulo P, Lindor KD 1999 Primary biliary cirrhosis and primary sclerosing cholangitis.
Clin. Liver Dis. 3: 529-570.
*
-
Angulo P, Lindor KD 2002 Non-alcoholic fatty liver disease.
J. Gastroenterol. Hepatol. 17 Suppl.: 186S-190S.
*
-
Angulo P, Lindor KD 2002 Treatment of non-alcoholic steatohepatitis.
Best Pract. Res. Clin. Gastroenterol. 16: 797-810.
*
-
Angulo P, Lindor KD 2001 Treatment of nonalcoholic fatty liver: present and emerging therapies.
Semin. Liver Dis. 21: 81-88.
-
Anheim M, Degos B, Echaniz-Laguna A, Fleury M, Grucker M, Tranchant C 2006 Ataxia associated with gluten sensitivity, myth or reality?
Rev. Neurol. (Paris) 162: 214-221.
-
Anjos S, Polychronakos C 2004 Mechanisms of genetic susceptibility to type I diabetes: beyond HLA.
Mol. Genet. Metab. 81: 187-195.
*
-
Anjos SM, Tessier MC, Polychronakos C 2004 Association of the cytotoxic T lymphocyte-associated antigen 4 gene with type 1 diabetes: evidence for independent effects of two polymorphisms on the same haplotype block.
J. Clin. Endocrinol. Metab. 89: 6257-6265.
*
-
Ansari MJ, Sayegh MH 2006 Costimulation couture: a designer approach to regulating autoimmunity.
J. Clin. Invest. 116: 2080-2083.
*
-
Antinozzi PA, Garcia-Diaz A, Hu C, Rothman JE 2006 Functional mapping of disease susceptibility loci using cell biology.
Proc. Natl. Acad. Sci. U.S.A. 103: 3698-3703.
*
-
Antoine HJ, Pall M, Trader BC, Chen YD, Azziz R, Goodarzi MO 2007 Genetic variants in peroxisome proliferator-activated receptor gamma influence insulin resistance and testosterone levels in normal women, but not those with polycystic ovary syndrome.
Fertil. Steril. 87: 862-869.
*
-
Antolic B, Gersak K, Verdenik I, Novak-Antolic Z 2006 Adverse effects of thyroid dysfunction on pregnancy and pregnancy outcome: epidemiologic study in Slovenia.
J. Matern. Fetal Neonatal Med. 19: 651-654.
-
Antonelli A, Ferri C, Ferrari SM, Colaci M, Fallahi P 2008 Immunopathogenesis of HCV-related endocrine manifestations in chronic hepatitis and mixed cryoglobulinemia.
Autoimmun. Rev. Aug 12 [Epub ahead of print].
-
Anuradha S, Radha V, Deepa R, Hansen T, Carstensen B, Pedersen O, Mohan V 2005 A prevalent amino acid polymorphism at codon 98 (Ala98Val) of the hepatocyte nuclear factor-1alpha is associated with maturity-onset diabetes of the young and younger age at onset of type 2 diabetes in Asian Indians.
Diabetes Care 28: 2430-2435.
*
-
Aoki CA, Borchers AT, Ridgway WM, Keen CL, Ansari AA, Gershwin ME 2005 NOD mice and autoimmunity.
Autoimmun. Rev. 4: 373-379.
-
Aoki K, Taniyama M, Nagayama C, Oikawa Y, Shimada A 2006 T cell immunity to glutamic acid decarboxylase in fulminant type 1 diabetes without significant elevation of serum amylase.
Ann. N. Y. Acad. Sci. 1079: 181-185.
*
-
Arafat HA, Lada E, Katakam AK, Amin N 2006 Osteopontin deficiency impacts the pancreatic TH1/TH2 cytokine profile following multiple low dose streptozotocin-induced diabetes.
Exp. Clin. Endocrinol. Diabetes 114: 555-562.
-
Arakawa Y, Kobayashi H, Ozaki T, Ariga H, Matsuo Y, Honda T, Arai T, Kurosu Y, Morita K, Konuma H, et al 1984 Serum determination of CA 19-9 in patients with digestive cancers and its diagnostic evaluation.
Gan. To. Kagaku. Ryoho. 11: 917-925.
-
Araki E, Igata M, Motoshima H, Tsuruzoe K 2005 Polymorphisms of PPARs and metabolic disorders.
Nippon Rinsho 63: 617-622.
-
Arason GJ 2008 The association of complement with common connective tissue diseases - a review.
Laeknabladid. 94: 371-374.
-
Arason GJ, Kolka R, Hreidarsson AB, Gudjonsson H, Schneider PM, Fry L, Arnason A 2005 Defective prevention of immune precipitation in autoimmune diseases is independent of C4A*Q0.
Clin. Exp. Immunol. 140: 572-579.
*
-
Araujo EP, De Souza CT, Ueno M, Cintra DE, Bertolo MB, Carvalheira JB, Saad MJ, Velloso LA 2007 Infliximab restores glucose homeostasis in an animal model of diet-induced obesity and diabetes.
Endocrinology 148: 5991-5997.
*
-
Araujo J, Brandao LA, Guimaraes RL, Santos S, Falcao EA, Milanese M, Segat L, Souza PR, de Lima-Filho JL, Crovella S 2008 Prevalence of autoimmune thyroid disease and thyroid dysfunction in young Brazilian patients with type 1 diabetes.
Pediatr. Diabetes 9: 272-276.
-
Araujo J, Brandao LA, Guimaraes RL, Santos S, Falcao EA, Milanese M, Segat L, Souza PR, de Lima-Filho JL, Crovella S 2007 Mannose binding lectin gene polymorphisms are associated with type 1 diabetes in Brazilian children and adolescents.
Hum. Immunol. 68: 739-743.
-
Araujo J, da Silva GA, de Melo FM 2006 Serum prevalence of celiac disease in children and adolescents with type 1 diabetes mellitus.
J. Pediatr. (Rio J.) 82: 210-214.
*
-
Araujo J, Silva GA, Melo FM 2006 Prevalence of celiac disease in children and adolescents with type 1 diabetes - authors' reply.
J. Pediatr. (Rio J.) 82: 401.
-
Ardesjo B, Hansson CM, Bruder CE, Rorsman F, Betterle C, Dumanski JP, Kampe O, Ekwall O 2008 Autoantibodies to glutathione S-transferase theta 1 in patients with primary sclerosing cholangitis and other autoimmune diseases.
J. Autoimmun. 30: 273-282.
-
Arefanian H, Tredget EB, Rajotte RV, Korbutt GS, Gill RG, Rayat GR 2007 Combination of anti-CD4 with anti-LFA-1 and anti-CD154 monoclonal antibodies promotes long-term survival and function of neonatal porcine islet xenografts in spontaneously diabetic NOD mice.
Cell. Transplant. 16: 787-798.
-
Arfa I, Abid A, Nouira S, Elloumi-Zghal H, Malouche D, Mannai I, Zorgati MM, Ben Alaya N, Rebai A, Zouari B, Ben Ammar S, Ben Rayana MC, Hmida S, Blousa-Chabchoub S, Abdelhak S 2008 Lack of association between the angiotensin-converting enzyme gene (I/D) polymorphism and diabetic nephropathy in Tunisian type 2 diabetic patients.
J. Renin Angiotensin Aldosterone Syst. 9: 32-36.
-
Aribi M 2008 Candidate genes implicated in type 1 diabetes susceptibility.
Curr. Diabetes Rev. 4: 110-121.
-
Arico M, Girschikofsky M, Genereau T, Klersy C, McClain K, Grois N, Emile JF, Lukina E, De Juli E, Danesino C 2003 Langerhans cell histiocytosis in adults. Report from the International Registry of the Histiocyte Society.
Eur. J. Cancer 39: 2341-2348.
*
-
Aridor M 2007 Visiting the ER: the endoplasmic reticulum as a target for therapeutics in traffic related diseases.
Adv. Drug Deliv. Rev. 59: 759-781.
-
Arif S, Tree TI, Astill TP, Tremble JM, Bishop AJ, Dayan CM, Roep BO, Peakman M 2004 Autoreactive T cell responses show proinflammatory polarization in diabetes but a regulatory phenotype in health.
J. Clin. Invest. 113: 451-463.
*
-
Arkan MC, Hevener AL, Greten FR, Maeda S, Li ZW, Long JM, Wynshaw-Boris A, Poli G, Olefsky J, Karin M 2005 IKK-beta links inflammation to obesity-induced insulin resistance.
Nat. Med. 11: 191-198.
*
-
Arkkila PE 2006 Thromboangiitis obliterans (Buerger's disease).
Orphanet J. Rare Dis. 1: 14.
*
-
Armagan O, Ekim A, Dinc A, Oner C 2007 Ankylosing spondylitis in a patient with Turner syndrome: a case report.
Rheumatol. Int. 27: 1177-1180.
*
-
Arnaiz-Villena A, Martinez-Laso J, Corell A, Allende L, Rosal M, Gomez-Reino JJ, Vicario JL 1996 Frequencies of HLA-A24 and HLA-DR4-DQ8 are increased and that of HLA-B blank is decreased in chronic toxic oil syndrome.
Eur. J. Immunogenet. 23: 211-219.
-
Arnson Y, Amital H, Shoenfeld Y 2007 Vitamin D and autoimmunity: new aetiological and therapeutic considerations.
Ann. Rheum. Dis. 66: 1137-1142.
*
-
Arredondo M, Jorquera D, Carrasco E, Albala C, Hertrampf E 2007 Microsatellite polymorphism in the heme oxygenase-1 gene promoter is associated with iron status in persons with type 2 diabetes mellitus.
Am. J. Clin. Nutr. 86: 1347-1353.
*
-
Arroyo A, Perez-Vicente F, Serrano P, Candela F, Sanchez A, Teresa Perez-Vazquez M, Calpena R 2005 Treatment of chronic anal fissure.
Cir. Esp. 78: 68-74.
-
Arrue I, Saiz A, Ortiz-Romero PL, Rodriguez-Peralto JL 2007 Lupus-like reaction to interferon at the injection site: report of five cases.
J. Cutan. Pathol. 34 Suppl. 1: 18-21.
-
Artwohl M, Lindenmair A, Sexl V, Maier C, Rainer G, Freudenthaler A, Huttary N, Wolzt M, Nowotny P, Luger A, Baumgartner-Parzer SM 2008 Different mechanisms of saturated versus polyunsaturated free fatty acid-induced apoptosis in human endothelial cells.
J. Lipid Res. Aug 5 [Epub ahead of print].
*
-
Artz E, Warren-Ulanch J, Becker D, Greenspan S, Freemark M 2008 Seropositivity to celiac antigens in asymptomatic children with type 1 diabetes mellitus: association with weight, height, and bone mineralization.
Pediatr. Diabetes 9: 277-284.
-
Asaki T, Aoki T, Hamamoto T, Sugiyama Y, Ohmachi S, Kuwabara K, Murakami K, Todo M 2008 Structure-activity studies on 1,3-dioxane-2-carboxylic acid derivatives, a novel class of subtype-selective peroxisome proliferator-activated receptor alpha (PPARalpha) agonists.
Bioorg. Med. Chem. 16: 981-994.
*
-
Asano K, Ikegami H, Fujisawa T, Kawabata Y, Noso S, Hiromine Y, Ogihara T 2006 The gene for human IL-21 and genetic susceptibility to type 1 diabetes in the Japanese.
Ann. N. Y. Acad. Sci. 1079: 47-50.
*
-
Asano K, Ikegami H, Fujisawa T, Nishino M, Nojima K, Kawabata Y, Noso S, Hiromine Y, Fukai A, Ogihara T 2007 Molecular scanning of interleukin-21 gene and genetic susceptibility to type 1 diabetes.
Hum. Immunol. 68: 384-391.
-
Asnani S, Theuma P, Fonseca VA 2003 PPARgamma agonists and vascular risk factors: potential effects on cardiovascular disease.
Metab. Syndr. Relat. Disord. 1: 23-32.
-
Aso Y, Matsuura H, Momobayashi A, Inukai Y, Sugawara N, Nakano T, Yamamoto R, Wakabayashi S, Takebayashi K, Inukai T 2006 Profound reduction in T-helper (Th) 1 lymphocytes in peripheral blood from patients with concurrent type 1 diabetes and Graves' disease.
Endocr. J. 53: 377-385.
*
-
Assisi A, Banzi R, Buonocore C, Capasso F, Muzio VD, Michelacci F, Renzo D, Tafuri G, Trotta F, Vitocolonna M, Garattini S 2006 Fish oil and mental health: the role of n-3 long-chain polyunsaturated fatty acids in cognitive development and neurological disorders.
Int. Clin. Psychopharmacol. 21: 319-336.
-
Atassi MZ, Casali P 2008 Molecular mechanisms of autoimmunity.
Autoimmunity 41: 123-132.
-
Atherton HJ, Bailey NJ, Zhang W, Taylor J, Major H, Shockcor J, Clarke K, Griffin JL 2006 A combined 1H NMR spectroscopy and mass spectrometry-based metabolomic study of the PPAR-alpha null mutant mouse defines profound systemic changes in metabolism linked to the metabolic syndrome.
Physiol. Genomics 27: 178-186.
*
-
Athyros VG, Kakafika AI, Karagiannis A, Mikhailidis DP 2008 Do we need to consider inflammatory markers when we treat atherosclerotic disease?
Atherosclerosis 200: 1-12.
-
Athyros VG, Kakafika AI, Tziomalos K, Karagiannis A, Mikhailidis DP 2008 Antisense technology for the prevention or the treatment of cardiovascular disease: the next blockbuster?
Expert Opin. Investig. Drugs 17: 969-972.
-
Attali P, Ink O, Pelletier G, Vernier C, Jean F, Moulton L, Etienne JP 1987 Dupuytren's contracture, alcohol consumption, and chronic liver disease.
Arch. Intern. Med. 147: 1065-1067.
-
Attie AD, Flowers MT, Flowers JB, Groen AK, Kuipers F, Ntambi JM 2007 Stearoyl-CoA desaturase deficiency, hypercholesterolaemia, cholestasis and diabetes.
Novartis Found. Symp. 286: 47-53.
-
Augarten A, Berman H, Aviram M, Diver-Habber A, Akons H, Ben Tur L, Blau H, Kerem E, Rivlin J, Katznelson D, Szeinberg A, Kerem BS, Theodor L, Paret G, Yahav Y 2003 Serum CA 19-9 levels as a diagnostic marker in cystic fibrosis patients with borderline sweat tests.
Clin. Exp. Med. 3: 119-123.
*
-
Augarten A, Kerem BS, Yahav Y, Noiman S, Rivlin Y, Tal A, Blau H, Ben-Tur L, Szeinberg A, Kerem E, et al 1993 Mild cystic fibrosis and normal or borderline sweat test in patients with the 3849 + 10 kb C-->T mutation.
Lancet 342: 25-26.
-
Augarten A, Tov AB, Madgar I, Barak A, Akons H, Laufer J, Efrati O, Aviram M, Bentur L, Blau H, Paret G, Wilschanski M, Kerem BS, Yahav Y 2008 The changing face of the exocrine pancreas in cystic fibrosis: the correlation between pancreatic status, pancreatitis and cystic fibrosis genotype.
Eur. J. Gastroenterol. Hepatol. 20: 164-168.
-
Augstein P, Heinke P, Salzsieder E, Grimm R, Giebel J, Salzsieder C, Harrison LC 2008 Dominance of cytokine- over FasL-induced impairment of the mitochondrial transmembrane potential (Deltapsim) in the pancreatic beta-cell line NIT-1.
Diab. Vasc. Dis. Res. 5: 198-204.
-
Aune TM, Maas K, Moore JH, Olsen NJ 2003 Gene expression profiles in human autoimmune disease.
Curr. Pharm. Des. 9: 1905-1917.
-
Aune TM, Maas K, Parker J, Moore JH, Olsen NJ 2004 Profiles of gene expression in human autoimmune disease.
Cell. Biochem. Biophys. 40: 81-96.
-
Avagliano L, Grillo C, Prioli MA 2005 Congenital heart disease: a retrospective study of their frequency.
Minerva Ginecol. 57: 171-178.
-
Awais M, Sato M, Umezawa Y 2007 A fluorescent indicator to visualize ligand-induced receptor/coactivator interactions for screening of peroxisome proliferator-activated receptor gamma ligands in living cells.
Biosens. Bioelectron. 22: 2564-2569.
*
-
Awara WM, El-Sisi AE, El-Refaei M, El-Naa MM, El-Desoky K 2005 Insulinotropic and anti-inflammatory effects of rosiglitazone in experimental autoimmune diabetes.
Rev. Diabet. Stud. 2: 146-156.
*
-
Awata T, Kurihara S, Iitaka M, Takei S, Inoue I, Ishii C, Negishi K, Izumida T, Yoshida Y, Hagura R, Kuzuya N, Kanazawa Y, Katayama S 1998 Association of CTLA-4 gene A-G polymorphism (IDDM12 locus) with acute-onset and insulin-depleted IDDM as well as autoimmune thyroid disease (Graves' disease and Hashimoto's thyroiditis) in the Japanese population.
Diabetes 47: 128-129.
-
Aycan Z, Berberoglu M, Adiyaman P, Ergur AT, Ensari A, Evliyaoglu O, Siklar Z, Ocal G 2004 Latent autoimmune diabetes mellitus in children (LADC) with autoimmune thyroiditis and Celiac disease.
J. Pediatr. Endocrinol. Metab. 17: 1565-1569.
-
Aydin E, Demir HD, Ozyurt H, Etikan I 2008 Association of plasma homocysteine and macular edema in type 2 diabetes mellitus.
Eur. J. Ophthalmol. 18: 226-232.
-
Ayela C, Roquet F, Valera L, Granier C, Nicu L, Pugniere M 2007 Antibody-antigenic peptide interactions monitored by SPR and QCM-D A model for SPR detection of IA-2 autoantibodies in human serum.
Biosens. Bioelectron. 22: 3113-3119.
-
Aygun C, Uraz S, Damci T, Osar Z, Yumuk V, Akdenizli E, Ilkova H 2005 Celiac disease in an adult Turkish population with type 1 diabetes mellitus.
Dig. Dis. Sci. 50: 1462-1466.
*
-
Ayse Selimoglu M, Ertekin V, Gursan N, Orbak Z, Esrefoglu M 2006 Brunner's gland hyperplasia in a child with diabetes mellitus and coeliac disease.
Acta Paediatr. 95: 508-510.
*
-
Azfar RS, Gelfand JM 2008 Psoriasis and metabolic disease: epidemiology and pathophysiology.
Curr. Opin. Rheumatol. 20: 416-422.
-
Azukizawa S, Kasai M, Takahashi K, Miike T, Kunishiro K, Kanda M, Mukai C, Shirahase H 2008 Synthesis and biological evaluation of (S)-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acids: a novel series of PPARgamma agonists.
Chem. Pharm. Bull. (Tokyo) 56: 335-345.
-
Azulay JP 2006 The extent of the clinical manifestations of chronic polyradiculoneuropathy.
Rev. Neurol. (Paris) 162: 518-521.
-
Babaya N, Nakayama M, Eisenbarth GS 2005 The stages of type 1A diabetes.
Ann. N. Y. Acad. Sci. 1051: 194-204.
*
-
Baccala R, Theofilopoulos AN 2005 The new paradigm of T-cell homeostatic proliferation-induced autoimmunity.
Trends Immunol. 26: 5-8.
*
-
Bach JF 2005 Infections and autoimmune diseases.
J. Autoimmun. 25: S74-S80.
-
Bach JF 2005 A Toll-like trigger for autoimmune disease.
Nat. Med. 11: 120-121.
*
-
Bach JF 2006 Induction of immunological tolerance using monoclonal antibodies: applications to organ transplantation and autoimmune disease.
C. R. Biol. 329: 260-262.
*
-
Bach JF, Chatenoud L 2001 Tolerance to islet autoantigens in type 1 diabetes.
Annu. Rev. Immunol. 19: 131-161.
*
-
Bach JF, Koutouzov S, van Endert PM 1998 Are there unique autoantigens triggering autoimmune diseases?
Immunol. Rev. 164: 139-155.
-
Bach JM, Otto H, Nepom GT, Jung G, Cohen H, Timsit J, Boitard C, van Endert PM 1997 High affinity presentation of an autoantigenic peptide in type I diabetes by an HLA class II protein encoded in a haplotype protecting from disease.
J. Autoimmun. 10: 375-386.
-
Bacher S, Schmitz ML 2004 The NF-kappa B pathway as a potential target for autoimmune disease therapy.
Curr. Pharm. Des. 10: 2827-2837.
-
Backes JM, Gibson CA, Ruisinger JF, Moriarty PM 2007 Fibrates: what have we learned in the past 40 years?
Pharmacotherapy 27: 412-424.
-
Bacon BR 1998 Iron overload states.
Clin. Liver Dis. 2: 63-75, vi.
-
Badenhoop K, Boehm BO 2004 Genetic susceptibility and immunological synapse in type 1 diabetes and thyroid autoimmune disease.
Exp. Clin. Endocrinol. Diabetes 112: 407-415.
-
Badenhoop K, Donner H, Pani M, Rau H, Siegmund T, Braun J 1999 Genetic susceptibility to type 1 diabetes: clinical and molecular heterogeneity of IDDM1 and IDDM12 in a German population.
Exp. Clin. Endocrinol. Diabetes 107 Suppl. 3: S89-S92.
-
Badenhoop K, Schwarz G, Trowsdale J, Lewis V, Usadel KH, Gale EA, Bottazzo GF 1989 TNF-alpha gene polymorphisms in type 1 (insulin-dependent) diabetes mellitus.
Diabetologia 32: 445-448.
-
Badenhoop K, Tonjes RR, Rau H, Donner H, Rieker W, Braun J, Herwig J, Mytilineos J, Kurth R, Usadel KH 1996 Endogenous retroviral long terminal repeats of the HLA-DQ region are associated with susceptibility to insulin-dependent diabetes mellitus.
Hum. Immunol. 50: 103-110.
-
Badenhoop K, Walfish PG, Rau H, Fischer S, Nicolay A, Bogner U, Schleusener H, Usadel KH 1995 Susceptibility and resistance alleles of human leukocyte antigen (HLA) DQA1 and HLA DQB1 are shared in endocrine autoimmune disease.
J. Clin. Endocrinol. Metab. 80: 2112-2117.
*
-
Badii R, Bener A, Zirie M, Al-Rikabi A, Simsek M, Al-Hamaq AO, Ghoussaini M, Froguel P, Wareham NJ 2008 Lack of association between the Pro(12)Ala polymorphism of the PPAR-gamma2 gene and type 2 diabetes mellitus in the Qatari consanguineous population.
Acta Diabetol. 45: 15-21.
*
-
Badman MK, Flier JS 2005 The gut and energy balance: visceral allies in the obesity wars.
Science 307: 1909-1914.
*
-
Baeke F, Etten EV, Gysemans C, Overbergh L, Mathieu C 2008 Vitamin D signaling in immune-mediated disorders: evolving insights and therapeutic opportunities.
Mol. Aspects Med. Jul 12 [Epub ahead of print].
-
Baev DV, Caielli S, Ronchi F, Coccia M, Facciotti F, Nichols KE, Falcone M 2008 Impaired SLAM-SLAM homotypic interaction between invariant NKT cells and dendritic cells affects differentiation of IL-4/IL-10-secreting NKT2 cells in nonobese diabetic mice.
J. Immunol. 181: 869-877.
-
Bagley J, Tian C, Iacomini J 2008 Prevention of type 1 diabetes in NOD mice by genetic engineering of hematopoietic stem cells.
Methods Mol. Biol. 433: 277-286.
-
Bahr MJ, Ockenga J, Boker KH, Manns MP, Tietge UJ 2006 Elevated resistin levels in cirrhosis are associated with the proinflammatory state and altered hepatic glucose metabolism but not with insulin resistance.
Am. J. Physiol. Endocrinol. Metab. 291: E199-E206.
*
-
Bahtiyar G, Shin JJ, Aytaman A, Sowers JR, McFarlane SI 2004 Association of diabetes and hepatitis C infection: epidemiologic evidence and pathophysiologic insights.
Curr. Diab. Rep. 4: 194-198.
-
Baier LJ, Permana PA, Traurig M, Dobberfuhl A, Wiedrich C, Sutherland J, Thuillez P, Luczy-Bachman G, Hara M, Horikawa Y, Hinokio Y, Hanson RL, Bogardus C 2000 Mutations in the genes for hepatocyte nuclear factor (HNF)-1alpha, -4alpha, -1beta, and -3beta; the dimerization cofactor of HNF-1; and insulin promoter factor 1 are not common causes of early-onset type 2 diabetes in Pima Indians.
Diabetes Care 23: 302-304.
*
-
Bailey CJ 2005 Drugs on the horizon for diabesity.
Curr. Diab. Rep. 5: 353-359.
-
Bailey SD, Loredo-Osti JC, Lepage P, Faith J, Fontaine J, Desbiens KM, Hudson TJ, Bouchard C, Gaudet D, Perusse L, Vohl MC, Engert JC 2006 Common polymorphisms in the promoter of the visfatin gene (PBEF1) influence plasma insulin levels in a French-Canadian population.
Diabetes 55: 2896-2902.
*
-
Bajaj M, Suraamornkul S, Hardies LJ, Glass L, Musi N, Defronzo RA 2007 Effects of peroxisome proliferator-activated receptor (PPAR)-alpha and PPAR-gamma agonists on glucose and lipid metabolism in patients with type 2 diabetes mellitus.
Diabetologia 50: 1723-1731.
*
-
Bak H, Lee JW, Ahn HJ, Hwang SM, Choi EH, Lee SH, Ahn SK 2006 An unusual case with membranous lipodystrophy in a hypertensive patient with transepidermal elimination.
Yonsei. Med. J. 47: 428-431.
*
-
Baker C, Petrich de Marquesini LG, Bishop AJ, Hedges AJ, Dayan CM, Wong FS 2008 Human CD8 responses to a complete epitope set from preproinsulin: implications for approaches to epitope discovery.
J. Clin. Immunol. 28: 350-360.
*
-
Bakke AC, Purtzer MZ, Wildin RS 2004 Prospective immunological profiling in a case of immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX).
Clin. Exp. Immunol. 137: 373-378.
*
-
Balakumar P, Rose M, Ganti SS, Krishan P, Singh M 2007 PPAR dual agonists: are they opening Pandora's box?
Pharmacol. Res. 56: 91-98.
*
-
Balakumar P, Rose M, Singh M 2007 PPAR ligands: are they potential agents for cardiovascular disorders?
Pharmacology 80: 1-10.
-
Balan V, Ruppert K, Demetris AJ, Ledneva T, Duquesnoy RJ, Detre KM, Wei YL, Rakela J, Schafer DF, Roberts JP, Everhart JE, Wiesner RH 2008 Long-term outcome of human leukocyte antigen mismatching in liver transplantation: results of the national institute of diabetes and digestive and kidney diseases liver transplantation database.
Hepatology 48: 878-888.
-
Balasubramanyam A, Nalini R, Hampe CS, Maldonado M 2008 Syndromes of ketosis-prone diabetes mellitus.
Endocr. Rev. 29: 292-302.
*
-
Balducci-Silano PL, Layrisse ZE 1995 HLA-DP and susceptibility to insulin-dependent diabetes mellitus in an ethnically mixed population. Associations with other HLA-alleles.
J. Autoimmun. 8: 425-437.
-
Balistreri WF 2007 Celiac disease and type 1 diabetes: to screen or not to screen?
J. Pediatr. 150: a1.
*
-
Ballarini A, Lee-Kirsch MA 2007 Genetic dissection of autoimmune polyendocrine syndrome type 2: common origin of a spectrum of phenotypes.
Ann. N. Y. Acad. Sci. 1110: 159-165.
-
Ballotti S, de Martino M 2007 Rotavirus infections and development of type 1 diabetes: an evasive conundrum.
J. Pediatr. Gastroenterol. Nutr. 45: 147-156.
*
-
Bamoulid J, Courivaud C, Deschamps M, Mercier P, Ferrand C, Penfornis A, Tiberghien P, Chalopin JM, Saas P, Ducloux D 2006 IL-6 promoter polymorphism -174 is associated with new-onset diabetes after transplantation.
J. Am. Soc. Nephrol. 17: 2333-2340.
-
Ban L, Zhang J, Wang L, Kuhtreiber W, Burger D, Faustman DL 2008 Selective death of autoreactive T cells in human diabetes by TNF or TNF receptor 2 agonism.
Proc. Natl. Acad. Sci. U.S.A. 105: 13644-13649.
*
-
Ban Y, Ban Y, Taniyama M, Katagiri T 2000 Vitamin D receptor initiation codon polymorphism in Japanese patients with Graves' disease.
Thyroid 10: 375-380.
-
Ban Y, Ban Y, Taniyama M, Katagiri T 2000 Vitamin D receptor initiation codon polymorphism in Japanese patients with Graves' disease.
Thyroid 10: 475-480.
-
Ban Y, Concepcion ES, Villanueva R, Greenberg DA, Davies TF, Tomer Y 2004 Analysis of immune regulatory genes in familial and sporadic Graves' disease.
J. Clin. Endocrinol. Metab. 89: 4562-4568.
*
-
Ban Y, Davies TF, Greenberg DA, Concepcion ES, Osman R, Oashi T, Tomer Y 2004 Arginine at position 74 of the HLA-DR beta1 chain is associated with Graves' disease.
Genes Immun. 5: 203-208.
*
-
Ban Y, Davies TF, Greenberg DA, Kissin A, Marder B, Murphy B, Concepcion ES, Villanueva RB, Barbesino G, Ling V, Tomer Y 2003 Analysis of the CTLA-4, CD28, and inducible costimulator (ICOS) genes in autoimmune thyroid disease.
Genes Immun. 4: 586-593.
*
-
Ban Y, Greenberg DA, Concepcion E, Skrabanek L, Villanueva R, Tomer Y 2003 Amino acid substitutions in the thyroglobulin gene are associated with susceptibility to human and murine autoimmune thyroid disease.
Proc. Natl. Acad. Sci. U.S.A. 100: 15119-15124.
*
-
Ban Y, Greenberg DA, Concepcion ES, Tomer Y 2002 A germline single nucleotide polymorphism at the intracellular domain of the human thyrotropin receptor does not have a major effect on the development of Graves' disease.
Thyroid 12: 1079-1083.
-
Ban Y, Taniyama M, Ban Y 2000 Vitamin D receptor gene polymorphism is associated with Graves' disease in the Japanese population.
J. Clin. Endocrinol. Metab. 85: 4639-4643.
*
-
Ban Y, Taniyama M, Tozaki T, Yanagawa T, Yamada S, Maruyama T, Kasuga A, Tomita M, Ban Y 2001 No association of type 1 diabetes with a microsatellite marker for CTLA-4 in a Japanese population.
Autoimmunity 34: 39-43.
-
Ban Y, Tomer Y 2005 Genetic susceptibility in thyroid autoimmunity.
Pediatr. Endocrinol. Rev. 3: 20-32.
-
Ban Y, Tomer Y 2005 Susceptibility genes in thyroid autoimmunity.
Clin. Dev. Immunol. 12: 47-58.
*
-
Ban Y, Tomer Y 2003 The contribution of immune regulatory and thyroid specific genes to the etiology of Graves' and Hashimoto's diseases.
Autoimmunity 36: 367-379.
-
Baniasadi V, Narain N, Goswami R, Das SN 2006 Promoter region -318 C/ T and -1661 A/G CTLA-4 single nucleotide polymorphisms and type 1 diabetes in North Indians.
Tissue Antigens 67: 383-389.
*
-
Banwell B, Bar-Or A, Cheung R, Kennedy J, Krupp LB, Becker DJ, Dosch HM; Wadsworth Pediatric Multiple Sclerosis Study Group 2008 Abnormal T-cell reactivities in childhood inflammatory demyelinating disease and type 1 diabetes.
Ann. Neurol. 63: 98-111.
-
Bao F, Babu SR, Roberts CM, Martin AK, Gowan K, Eisenbarth GS, Fain PR 2003 Single nucleotide polymorphism study of IDDM 17 in a Bedouin Arab family.
Ann. N. Y. Acad. Sci. 1005: 348-351.
-
Bao F, Yu L, Babu S, Wang T, Hoffenberg EJ, Rewers M, Eisenbarth GS 1999 One third of HLA DQ2 homozygous patients with type 1 diabetes express celiac disease-associated transglutaminase autoantibodies.
J. Autoimmun. 13: 143-148.
-
Bao S, Root C, Jagasia S 2007 Type B insulin resistance syndrome associated with systemic lupus erythematosus.
Endocr. Pract. 13: 51-55.
-
Baptista ML, Koda YK, Mitsunori R, Nisihara, Ioshii SO 2005 Prevalence of celiac disease in Brazilian children and adolescents with type 1 diabetes mellitus.
J. Pediatr. Gastroenterol. Nutr. 41: 621-624.
*
-
Baranowski M, Blachnio-Zabielska A, Zabielski P, Gorski J 2008 Pioglitazone induces lipid accumulation in the rat heart despite concomitant reduction in plasma free fatty acid availability.
Arch. Biochem. Biophys. 477: 86-91.
*
-
Barbato M, Viola F, Miglietta MR, Argo G, Iulianella VR, Di Giuseppe S, Pippa G, Gentiloni Silverj F, Lo Russo L, Frediani T, Lucarelli S, Multari G, Cardi E 1998 Association between insulin dependent diabetes mellitus and coeliac disease. A study on 175 diabetes patients.
Minerva Gastroenterol. Dietol. 44: 1-5.
-
Barbe-Tuana FM, Klein D, Ichii H, Berman DM, Coffey L, Kenyon NS, Ricordi C, Pastori RL 2006 CD40-CD40 ligand interaction activates proinflammatory pathways in pancreatic islets.
Diabetes 55: 2437-2445.
*
-
Barbeau WE, Bassaganya-Riera J, Hontecillas R 2007 Putting the pieces of the puzzle together - a series of hypotheses on the etiology and pathogenesis of type 1 diabetes.
Med. Hypotheses 68: 607-619.
-
Barbieri M, Marfella R, Rizzo MR, Boccardi V, Siniscalchi M, Schiattarella C, Siciliano S, Lemme P, Paolisso G 2008 The -8 UTR C/G polymorphism of PSMA6 gene is associated with susceptibility to myocardial infarction in type 2 diabetic patients.
Atherosclerosis Mar 19 [Epub ahead of print].
-
Barker JM 2006 Type 1 diabetes associated autoimmunity: natural history, genetic associations and screening.
J. Clin. Endocrinol. Metab. 91: 1210-1217.
*
-
Barker JM, Triolo TM, Aly TA, Baschal EE, Babu SR, Kretowski A, Rewers MJ, Eisenbarth GS 2008 Two single nucleotide polymorphisms identify highest-risk diabetes human leukocyte antigen genotype: potential for rapid screening.
Diabetes Aug 11 [Epub ahead of print].
-
Barker JM, Yu J, Yu L, Wang J, Miao D, Bao F, Hoffenberg E, Nelson JC, Gottlieb PA, Rewers M, Eisenbarth GS 2005 Autoantibody "subspecificity" in type 1 diabetes: risk for organ-specific autoimmunity clusters in distinct groups.
Diabetes Care 28: 850-855.
*
-
Barral AM, Thomas HE, Ling EM, Darwiche R, Rodrigo E, Christen U, Ejrnaes M, Wolfe T, Kay TW, von Herrath MG 2006 SOCS-1 protects from virally-induced CD8 T cell mediated type 1 diabetes.
J. Autoimmun. 27: 166-173.
-
Barre DE 2007 The role of consumption of alpha-linolenic, eicosapentaenoic and docosahexaenoic acids in human metabolic syndrome and type 2 diabetes - a mini-review.
J. Oleo. Sci. 56: 319-325.
*
-
Barrett JC, Hansoul S, Nicolae DL, Cho JH, Duerr RH, Rioux JD, Brant SR, Silverberg MS, Taylor KD, Barmada MM, Bitton A, Dassopoulos T, Datta LW, Green T, Griffiths AM, Kistner EO, Murtha MT, Regueiro MD, Rotter JI, et al 2008 Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease.
Nat. Genet. 40: 955-962.
*
-
Barritt AS 4th, Zacks SL, Rubinas TC, Herfarth HH 2008 Oral budesonide for the therapy of post-liver transplant de novo inflammatory bowel disease: a case series and systematic review of the literature.
Inflamm. Bowel Dis. Jul 10 [Epub ahead of print].
-
Barroso I, Luan J, Sandhu MS, Franks PW, Crowley V, Schafer AJ, O'rahilly S, Wareham NJ 2006 Meta-analysis of the Gly482Ser variant in PPARGC1A in type 2 diabetes and related phenotypes.
Diabetologia 49: 501-505.
*
-
Barter P 2006 Managing diabetic dyslipidaemia-beyond LDL-C:HDL-C and triglycerides.
Atheroscler. Suppl. 7: 17-21.
-
Barth A, Rost M, Kindt A, Peiker G 2005 Serum bile acid profile in women during pregnancy and childbed.
Exp. Clin. Endocrinol. Diabetes 113: 372-375.
-
Bartholo RM, Zaltman C, Elia C, Cardoso AP, Flores V, Lago P, Cassabian L, Carvalho Dorileo F, Lapa-E-Silva JR 2005 Bronchial hyperresponsiveness and analysis of induced sputum cells in Crohn's disease.
Braz. J. Med. Biol. Res. 38: 197-203.
*
-
Barton A, Jury F, Eyre S, Bowes J, Hinks A, Ward D, Worthington J 2004 Haplotype analysis in simplex families and novel analytic approaches in a case-control cohort reveal no evidence of association of the CTLA-4 gene with rheumatoid arthritis.
Arthritis Rheum. 50: 748-752.
*
-
Barton A, Myerscough A, John S, Gonzalez-Gay M, Ollier W, Worthington J 2000 A single nucleotide polymorphism in exon 1 of cytotoxic T-lymphocyte-associated-4 (CTLA-4) is not associated with rheumatoid arthritis.
Rheumatology (Oxford) 39: 63-66.
*
-
Bartsch DK, Kress R, Sina-Frey M, Grutzmann R, Gerdes B, Pilarsky C, Heise JW, Schulte KM, Colombo-Benkmann M, Schleicher C, Witzigmann H, Pridohl O, Ghadimi MB, Horstmann O, von Bernstorff W, Jochimsen L, Schmidt J, Eisold S, Estevez-Schwarz L, et al 2004 Prevalence of familial pancreatic cancer in Germany.
Int. J. Cancer 110: 902-906.
*
-
Bartsocas CS, Gerasimidi-Vazeou A 2006 Genetics of type 1 diabetes mellitus.
Pediatr. Endocrinol. Rev. 3 Suppl. 3: 508-513.
-
Basarkar A, Singh J 2008 Poly (lactide-co-glycolide)-polymethacrylate nanoparticles for intramuscular delivery of plasmid encoding interleukin-10 to prevent autoimmune diabetes in mice.
Pharm. Res. Sep 9 [Epub ahead of print].
-
Basch E, Bent S, Collins J, Dacey C, Hammerness P, Harrison M, Smith M, Szapary P, Ulbricht C, Vora M, Weissner W 2007 Flax and flaxseed oil (Linum usitatissimum): a review by the Natural Standard Research Collaboration.
J. Soc. Integr. Oncol. 5: 92-105.
-
Bassuny WM, Ihara K, Matsuura N, Ahmed S, Kohno H, Kuromaru R, Miyako K, Hara T 2002 Association study of the NRAMP1 gene promoter polymorphism and early-onset type 1 diabetes.
Immunogenetics 54: 282-285.
*
-
Bastian HM, Alarcon GS, Roseman JM, McGwin G Jr, Vila LM, Fessler BJ, Reveille JD 2007 Systemic lupus erythematosus in a multiethnic US cohort (LUMINA) XL II: factors predictive of new or worsening proteinuria.
Rheumatology (Oxford) 46: 683-689.
*
-
Basu A, Jensen MD, McCann F, Nandy D, Mukhopadhyay D, McConnell JP, Rizza RA 2007 Lack of an effect of pioglitazone or glipizide on lipoprotein-associated phospholipase A2 in type 2 diabetes.
Endocr. Pract. 13: 147-152.
-
Basu SK, Govardhan CP, Jung CW, Margolin AL 2004 Protein crystals for the delivery of biopharmaceuticals.
Expert Opin. Biol. Ther. 4: 301-317.
-
Battaglia M, Roncarolo MG 2007 In vivo neutralization of inflammatory cytokines might not be necessary for regulatory T-cell immunotherapy.
Nat. Rev. Immunol. Nov 30 [Epub ahead of print].
*
-
Battezzati A, Battezzati PM, Costantini D, Seia M, Zazzeron L, Russo MC, Dacco V, Bertoli S, Crosignani A, Colombo C 2007 Spontaneous hypoglycemia in patients with cystic fibrosis.
Eur. J. Endocrinol. 156: 369-376.
*
-
Baum H, Staines NA 1997 MHC-derived peptides and the CD4+ T-cell repertoire: implications for autoimmune disease.
Cytokines Cell Mol. Ther. 3: 115-125.
-
Baxter A, Jordan M, Silveira P, Wilson W, Van Driel I 2005 Genetic control of susceptibility to autoimmune gastritis.
Int. Rev. Immunol. 24: 55-62.
-
Baxter AG 1997 Immunogenetics and the cause of autoimmune disease.
Autoimmunity 25: 177-189.
*
-
Beasley RP 2006 Diabetes and hepatocellular carcinoma.
Hepatology 44: 1408-1410.
*
-
Beauquis J, Homo-Delarche F, Revsin Y, De Nicola AF, Saravia F 2008 Brain alterations in autoimmune and pharmacological models of diabetes mellitus: focus on hypothalamic-pituitary-adrenocortical axis disturbances.
Neuroimmunomodulation 15: 61-67.
-
Beauquis J, Saravia F, Coulaud J, Roig P, Dardenne M, Homo-Delarche F, De Nicola A 2008 Prominently decreased hippocampal neurogenesis in a spontaneous model of type 1 diabetes, the nonobese diabetic mouse.
Exp. Neurol. 210: 359-367.
-
Beaven SW, Tontonoz P 2006 Nuclear receptors in lipid metabolism: targeting the heart of dyslipidemia.
Annu. Rev. Med. 57: 313-329.
*
-
Becker A, Smulders YM, van Guldener C, Stehouwer CD 2003 Epidemiology of homocysteine as a risk factor in diabetes.
Metab. Syndr. Relat. Disord. 1: 105-120.
-
Becker D, Enk A, Brauninger W, Knop J 1995 Granuloma anulare disseminatum as a rare side effect of allopurinol.
Hautarzt. 46: 343-345.
-
Becker H, Weber C, Storch S, Federlin K 1990 Relationship between CD5+ B lymphocytes and the activity of systemic autoimmunity.
Clin. Immunol. Immunopathol. 56: 219-225.
-
Becker J, Delayre-Orthez C, Frossard N, Pons F 2006 Regulation of inflammation by PPARs: a future approach to treat lung inflammatory diseases?
Fundam. Clin. Pharmacol. 20: 429-447.
*
-
Becker KG 1999 Comparative genetics of type 1 diabetes and autoimmune disease: common loci, common pathways?
Diabetes 48: 1353-1358.
*
-
Becker KG 2004 The common variants/multiple disease hypothesis of common complex genetic disorders.
Med. Hypotheses 62: 309-317.
-
Becker KG, Simon RM, Bailey-Wilson JE, Freidlin B, Biddison WE, McFarland HF, Trent JM 1998 Clustering of non-major histocompatibility complex susceptibility candidate loci in human autoimmune diseases.
Proc. Natl. Acad. Sci. U.S.A. 95: 9979-9984.
*
-
Beeton C, Smith BJ, Sabo JK, Crossley G, Nugent D, Khaytin I, Chi V, Chandy KG, Pennington MW, Norton RS 2008 The D-diastereomer of SHK toxin selectively blocks voltage-gated K+ channels and inhibits T lymphocyte proliferation.
J. Biol. Chem. 283: 988-997.
*
-
Beeton C, Wulff H, Standifer NE, Azam P, Mullen KM, Pennington MW, Kolski-Andreaco A, Wei E, Grino A, Counts DR, Wang PH, Leehealey CJ, S Andrews B, Sankaranarayanan A, Homerick D, Roeck WW, Tehranzadeh J, Stanhope KL, Zimin P, Havel PJ, Griffey S, et al 2006 Kv1.3 channels are a therapeutic target for T cell-mediated autoimmune diseases.
Proc. Natl. Acad. Sci. U.S.A. 103: 17414-17419.
*
-
Befeler AS 2003 New developments in hepatocellular carcinoma.
54th Annual Meeting of the American Association for the Study of Liver Diseases.
-
Begovich AB, Carlton VE, Honigberg LA, Schrodi SJ, Chokkalingam AP, Alexander HC, Ardlie KG, Huang Q, Smith AM, Spoerke JM, Conn MT, Chang M, Chang SY, Saiki RK, Catanese JJ, Leong DU, Garcia VE, McAllister LB, Jeffery DA, Lee AT, Batliwalla F, et al 2004 A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis.
Am. J. Hum. Genet. 75: 330-337.
*
-
Beilhack GF, Landa RR, Masek MA, Shizuru JA 2005 Prevention of type 1 diabetes with major histocompatibility complex-compatible and nonmarrow ablative hematopoietic stem cell transplants.
Diabetes 54: 1770-1779.
*
-
Bekris LM, Shephard C, Janer M, Graham J, McNeney B, Shin J, Zarghami M, Griffith W, Farin F, Kavanagh TJ, Lernmark A 2007 Glutamate cysteine ligase catalytic subunit promoter polymorphisms and associations with type 1 diabetes age-at-onset and GAD65 autoantibody levels.
Exp. Clin. Endocrinol. Diabetes 115: 221-228.
-
Bekris LM, Shephard C, Peterson M, Hoehna J, Yserloo BV, Rutledge E, Farin F, Kavanagh TJ, Lernmark A 2005 Glutathione-S-transferase M1 and T1 polymorphisms and associations with type 1 diabetes age-at-onset.
Autoimmunity 38: 567-575.
-
Belanger S, Tai LH, Anderson SK, Makrigiannis AP 2008 Ly49 cluster sequence analysis in a mouse model of diabetes: an expanded repertoire of activating receptors in the NOD genome.
Genes Immun. 9: 509-521.
-
Belfort R, Harrison SA, Brown K, Darland C, Finch J, Hardies J, Balas B, Gastaldelli A, Tio F, Pulcini J, Berria R, Ma JZ, Dwivedi S, Havranek R, Fincke C, DeFronzo R, Bannayan GA, Schenker S, Cusi K 2006 A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis.
N. Engl. J. Med. 355: 2297-2307.
*
-
Bell DS, Allbright E 2007 The multifaceted associations of hepatobiliary disease and diabetes.
Endocr. Pract. 13: 300-312.
-
Bell H, Berg JP, Undlien DE, Distante S, Raknerud N, Heier HE, Try K, Thomassen Y, Haug E, Raha-Chowdhury R, Thorsby E 2000 The clinical expression of hemochromatosis in Oslo, Norway. Excessive oral iron intake may lead to secondary hemochromatosis even in HFE C282Y mutation negative subjects.
Scand. J. Gastroenterol. 35: 1301-1307.
*
-
Bell J, Rassenti L, Smoot S, Smith K, Newby C, Hohlfeld R, Toyka K, McDevitt H, Steinman L 1986 HLA-DQ beta-chain polymorphism linked to myasthenia gravis.
Lancet 1: 1058-1060.
-
Bell JI 1987 The molecular genetics of HLA-related disorders.
Ciba Found. Symp. 130: 197-214.
-
Bell JK, Askins J, Hall PR, Davies DR, Segal DM 2006 The dsRNA binding site of human Toll-like receptor 3.
Proc. Natl. Acad. Sci. U.S.A. 103: 8792-8797.
*
-
Bell JK, Botos I, Hall PR, Askins J, Shiloach J, Davies DR, Segal DM 2006 The molecular structure of the TLR3 extracellular domain.
J. Endotoxin Res. 12: 375-378.
-
Bell JK, Botos I, Hall PR, Askins J, Shiloach J, Segal DM, Davies DR 2005 The molecular structure of the Toll-like receptor 3 ligand-binding domain.
Proc. Natl. Acad. Sci. U.S.A. 102: 10976-10980.
*
-
Belniak E, Stelmasiak Z, Papuc E 2007 Multiple sclerosis and other autoimmune diseases.
Neurol. Neurochir. Pol. 41: 259-266.
-
Belvisi MG, Hele DJ, Birrell MA 2006 Peroxisome proliferator-activated receptor gamma agonists as therapy for chronic airway inflammation.
Eur. J. Pharmacol. 533: 101-109.
*
-
Ben-Menachem T 2007 Risk factors for cholangiocarcinoma.
Eur. J. Gastroenterol. Hepatol. 19: 615-617.
-
Bendlova B, Vejralkova D, Vcelak J, Lukalova P, Burkonova D, Kunelova M, Vrbikova J, Dvorakova K, Vondra K, Vankova M 2008 PPARgamma2 Pro12Ala polymorphism in relation to free fatty acids concentration and composition in lean healthy Czech individuals with and without family history of diabetes type 2.
Physiol. Res. 57 Suppl. 1: S77-S90.
-
Bengmark S 2006 Curcumin, an atoxic antioxidant and natural NFkappaB, cyclooxygenase-2, lipooxygenase, and inducible nitric oxide synthase inhibitor: a shield against acute and chronic diseases.
JPEN J. Parenter. Enteral Nutr. 30: 45-51.
*
-
Bengmark S 2007 Advanced glycation and lipoxidation end products amplifiers of inflammation: the role of food.
JPEN J. Parenter. Enteral Nutr. 31: 430-440.
*
-
Bengtson MB, Ronning T, Vatn M, Harris J 2006 Irritable bowel syndrome in twins: genes and environment.
Gut 55: 1754-1759.
*
-
Benn CS, Aaby P 2007 Sex-differential responses to preventive health interventions. Maybe we treat boys and girls differently when we treat them equally? - Secondary publication.
Dan. Med. Bull. 54: 153-154.
-
Bennett AJ, Sovio U, Ruokonen A, Martikainen H, Pouta A, Hartikainen AL, Franks S, Elliott P, Jarvelin MR, McCarthy MI 2008 No evidence that established type 2 diabetes susceptibility variants in the PPARG and KCNJ11 genes have pleiotropic effects on early growth.
Diabetologia 51: 82-85.
*
-
Bennett ST, Wilson AJ, Cucca F, Nerup J, Pociot F, McKinney PA, Barnett AH, Bain SC, Todd JA 1996 IDDM2-VNTR-encoded susceptibility to type 1 diabetes: dominant protection and parental transmission of alleles of the insulin gene-linked minisatellite locus.
J. Autoimmun. 9: 415-421.
-
Benoist C, Germain RN, Mathis D 2006 A plaidoyer for 'systems immunology'.
Immunol. Rev. 210: 229-234.
*
-
Benoist C, Mathis D 2001 Autoimmunity provoked by infection: how good is the case for T cell epitope mimicry?
Nat. Immunol. 2: 797-801.
*
-
Bensing S, Brandt L, Tabaroj F, Sjoberg O, Nilsson B, Ekbom A, Blomqvist P, Kampe O 2008 Increased death risk and altered cancer incidence pattern in patients with isolated or combined autoimmune primary adrenocortical insufficiency.
Clin. Endocrinol. (Oxf.) Aug 22 [Epub ahead of print].
*
-
Benten D, Follenzi A, Bhargava KK, Kumaran V, Palestro CJ, Gupta S 2005 Hepatic targeting of transplanted liver sinusoidal endothelial cells in intact mice.
Hepatology 42: 140-148.
*
-
Bento JL, Palmer ND, Mychaleckyj JC, Lange LA, Langefeld CD, Rich SS, Freedman BI, Bowden DW 2004 Association of protein tyrosine phosphatase 1B gene polymorphisms with type 2 diabetes.
Diabetes 53: 3007-3012.
*
-
Beranek M, Kolar P, Tschoplova S, Kankova K, Vasku A 2008 Genetic variation and plasma level of the basic fibroblast growth factor in proliferative diabetic retinopathy.
Diabetes Res. Clin. Pract. 79: 362-367.
-
Berends MA, Snoek J, DE Jong EM, VAN DE Kerkhof PC, VAN Oijen MG, VAN Krieken JH, Drenth JP 2006 Liver injury in long-term methotrexate treatment in psoriasis is relatively infrequent.
Aliment. Pharmacol. Ther. 24: 805-811.
*
-
Bergasa NV, Alling DW, Talbot TL, Wells MC, Jones EA 1999 Oral nalmefene therapy reduces scratching activity due to the pruritus of cholestasis: a controlled study.
J. Am. Acad. Dermatol. 41: 431-434.
-
Bergasa NV, Schmitt JM, Talbot TL, Alling DW, Swain MG, Turner ML, Jenkins JB, Jones EA 1998 Open-label trial of oral nalmefene therapy for the pruritus of cholestasis.
Hepatology 27: 679-684.
*
-
Bergasa NV, Talbot TL, Alling DW, Schmitt JM, Walker EC, Baker BL, Korenman JC, Park Y, Hoofnagle JH, Jones EA 1992 A controlled trial of naloxone infusions for the pruritus of chronic cholestasis.
Gastroenterology 102: 544-549.
-
Bergasa NV, Vergalla J, Turner ML, Loh PY, Jones EA 1993 Alpha-melanocyte-stimulating hormone in primary biliary cirrhosis.
Ann. N. Y. Acad. Sci. 680: 454-458.
-
Berger J, Moller DE 2002 The mechanisms of action of PPARs.
Annu. Rev. Med. 53: 409-435.
*
-
Berger J, Wagner JA 2002 Physiological and therapeutic roles of peroxisome proliferator-activated receptors.
Diabetes Technol. Ther. 4: 163-174.
-
Berger JP, Akiyama TE, Meinke PT 2005 PPARs: therapeutic targets for metabolic disease.
Trends Pharmacol. Sci. 26: 244-251.
*
-
Berger JR, Weaver A, Greenlee J, Wahlen GE 2008 Neurologic consequences of autoimmune polyglandular syndrome type 1.
Neurology 70: 2248-2251.
-
Berger K, Stogbauer F, Stoll M, Wellmann J, Huge A, Cheng S, Kessler C, John U, Assmann G, Ringelstein EB, Funke H 2007 The glu298asp polymorphism in the nitric oxide synthase 3 gene is associated with the risk of ischemic stroke in two large independent case-control studies.
Hum. Genet. 121: 169-178.
*
-
Bergeron R, Yao J, Woods JW, Zycband EI, Liu C, Li Z, Adams A, Berger JP, Zhang BB, Moller DE, Doebber TW 2006 Peroxisome proliferator-activated receptor (PPAR)-alpha agonism prevents the onset of type 2 diabetes in ZDF rats: a comparison to PPARgamma agonism.
Endocrinology 147: 4252-4262.
*
-
Bergholdt R, Heding P, Nielsen K, Nolsoe R, Sparre T, Storling J, Nerup J, Pociot F, Mandrup-Poulsen T 2004 Type 1 database mellitus: an inflammatory disease of the islet.
Adv. Exp. Med. Biol. 552: 129-153.
-
Bergholdt R, Karlsen AE, Hagedorn PH, Aalund M, Nielsen JH, Kruhoffer M, Orntoft T, Wang H, Wollheim CB, Nerup J, Pociot F 2007 Transcriptional profiling of type 1 diabetes genes on chromosome 21 in a rat beta-cell line and human pancreatic islets.
Genes Immun. 8: 232-238.
*
-
Bergholdt R, Larsen ZM, Andersen NA, Johannesen J, Kristiansen OP, Mandrup-Poulsen T, Nerup J, Pociot F; Danish Study Group of IDDM in Childhood; Danish IDDM Epidemiology and Genetics Group 2000 Characterization of new polymorphisms in the 5' UTR of the human interleukin-1 receptor type 1 (IL1R1) gene: linkage to type 1 diabetes and correlation to IL-1RI plasma level.
Genes Immun. 1: 495-500.
*
-
Bergholdt R, Nerup J, Pociot F 2005 Fine mapping of a region on chromosome 21q21.11-q22.3 showing linkage to type 1 diabetes.
J. Med. Genet. 42: 17-25.
*
-
Bergholdt R, Taxvig C, Eising S, Nerup J, Pociot F 2005 CBLB variants in type 1 diabetes and their genetic interaction with CTLA4.
J. Leukoc. 77: 579-585.
*
-
Bergman ML, Cilio CM, Penha-Goncalves C, Lamhamedi-Cherradi SE, Lofgren A, Colucci F, Lejon K, Garchon HJ, Holmberg D 2001 CTLA-4-/- mice display T cell-apoptosis resistance resembling that ascribed to autoimmune-prone non-obese diabetic (NOD) mice.
J. Autoimmun. 16: 105-113.
-
Bergmann MM, Jacobs EJ, Hoffmann K, Boeing H 2004 Agreement of self-reported medical history: comparison of an in-person interview with a self-administered questionnaire.
Eur. J. Epidemiol. 19: 411-416.
-
Bergstrom JP, Helander A 2008 HPLC evaluation of clinical and pharmacological factors reported to cause false-positive carbohydrate-deficient transferrin (CDT) levels.
Clin. Chim. Acta 389: 164-166.
*
-
Berka N, Bland GN, Erabhaoui el H, Dunston GM 2007 Heat-shock protein gene is not associated with type-1 diabetes in African Americans.
J. Natl. Med. Assoc. 99: 715-717.
-
Berka N, Nunlee-Bland G, Erabhaoui E, Belmamoun M, Dunston GM 2004 IDDM2 and the polymorphism of the human tyrosine hydroxylase (hTH) gene in African Americans with type-1 diabetes.
J. Natl. Med. Assoc. 96: 1042-1046.
-
Berkovic M, Cacev T, Zjacic-Rotkvic V, Kapitanovic S 2006 TNF-alpha promoter single nucleotide polymorphisms in gastroenteropancreatic neuroendocrine tumors.
Neuroendocrinology 84: 346-352.
-
Bernal-Reyes R, Escudero RB 2002 Treatment of non-alcoholic steatohepatitis (NASH). A comparative study of ursodeoxycholic acid and alpha-tocopherol. A preliminary report.
Rev. Gastroenterol. Mex. 67: 70-75.
-
Bernardo A, Minghetti L 2008 Regulation of glial cell functions by PPAR-gamma natural and synthetic agonists.
PPAR Res. 2008: 864140.
*
-
Bersot T, Haffner S, Harris WS, Kellick KA, Morris CM 2006 Hypertriglyceridemia: management of atherogenic dyslipidemia.
J. Fam. Pract. 55: S1-S8.
-
Berthold HK, Laaksonen R, Lehtimaki T, Gylling H, Krone W, Gouni-Berthold I 2008 SREBP-1c gene polymorphism is associated with increased inhibition of cholesterol-absorption in response to ezetimibe treatment.
Exp. Clin. Endocrinol. Diabetes 116: 262-267.
-
Bertrams J 1984 The HLA association of insulin-dependent (type I) diabetes mellitus.
Behring Inst. Mitt. 75: 89-99.
-
Bertuzzi F, Ricordi C 2007 Beta-cell replacement in immunosuppressed recipients: old and new clinical indications.
Acta Diabetol. 44: 171-176.
-
Besin G, Gaudreau S, Menard M, Guindi C, Dupuis G, Amrani A 2008 Thymic stromal lymphopoietin and thymic stromal lymphopoietin-conditioned dendritic cells induce regulatory T-cell differentiation and protection of NOD mice against diabetes.
Diabetes 57: 2107-2117.
-
Besler C, Doerries C, Giannotti G, Luscher TF, Landmesse U 2008 Pharmacological approaches to improve endothelial repair mechanisms.
Expert Rev. Cardiovasc. Ther. 6: 1071-1082.
-
Bessa SS, Hamdy SM, Ali EM 2007 Haptoglobin gene polymorphism in type 2 diabetic patients with and without nephropathy: an Egyptian study.
Eur. J. Intern. Med. 18: 489-495.
-
Betteridge DJ 2001 Lipid-lowering trials in diabetes.
Curr. Opin. Lipidol. 12: 619-623.
-
Betterle C, Dalpra C, Greggio N, Volpato M, Zanchetta R 2001 Autoimmunity in isolated Addison's disease and in polyglandular autoimmune diseases type 1, 2 and 4.
Ann. Endocrinol. (Paris) 62: 193-201.
-
Betterle C, Lazzarotto F, Presotto F 2004 Autoimmune polyglandular syndrome type 2: the tip of an iceberg?
Clin. Exp. Immunol. 137: 225-233.
*
-
Betterle C, Rossi A, Dalla Pria S, Artifoni A, Pedini B, Gavasso S, Caretto A 1993 Premature ovarian failure: autoimmunity and natural history.
Clin. Endocrinol. (Oxf.) 39: 35-43.
-
Betterle C, Zanchetta R 2003 Update on autoimmune polyendocrine syndromes (APS).
Acta Biomed. Ateneo. Parmense. 74: 9-33.
-
Betts P, Mulligan J, Ward P, Smith B, Wilkin T 2005 Increasing body weight predicts the earlier onset of insulin-dependant diabetes in childhood: testing the 'accelerator hypothesis' (2).
Diabet. Med. 22: 144-151.
*
-
Beulens JW, Rimm EB, Hendriks HF, Hu FB, Manson JE, Hunter DJ, Mukamal KJ 2007 Alcohol consumption and type 2 diabetes: influence of genetic variation in alcohol dehydrogenase.
Diabetes 56: 2388-2394.
*
-
Beyan H, Buckley LR, Yousaf N, Londei M, Leslie RD 2003 A role for innate immunity in type 1 diabetes?
Diabetes Metab. Res. Rev. 19: 89-100.
-
Beyan H, Ola T, David R, Leslie G 2006 Progression of autoimmune diabetes: slowly progressive insulin-dependent diabetes mellitus or latent autoimmune diabetes of adult.
Ann. N. Y. Acad. Sci. 1079: 81-89.
*
-
Beylot M 1996 Regulation of in vivo ketogenesis: role of free fatty acids and control by epinephrine, thyroid hormones, insulin and glucagon.
Diabetes Metab. 22: 299-304.
-
Beysen C, Murphy EJ, Nagaraja H, Decaris M, Riiff T, Fong A, Hellerstein MK, Boyle PJ 2008 A pilot study of the effects of pioglitazone and rosiglitazone on de novo lipogenesis in type 2 diabetes.
J. Lipid Res. Jul 18 [Epub ahead of print].
*
-
Bhadada SK, Udawat HP, Bhansali A, Rana SS, Sinha SK, Bhasin DK 2008 Chronic pancreatitis in primary hyperparathyroidism: comparison with alcoholic and idiopathic chronic pancreatitis.
J. Gastroenterol. Hepatol. 23: 959-964.
*
-
Bhaskar S, Reddy DN, Mahurkar S, Rao GV, Singh L, Chandak GR 2006 Lack of significant association of an insertion/deletion polymorphism in the angiotensin converting enzyme (ACE) gene with tropical calcific pancreatitis.
BMC Gastroenterol. 6: 42.
*
-
Bhat A, Koul A, Rai E, Sharma S, Dhar MK, Bamezai RN 2007 PGC-1alpha Thr394Thr and Gly482Ser variants are significantly associated with T2DM in two North Indian populations: a replicate case-control study.
Hum. Genet. 121: 609-614.
*
-
Bhatia E, Choudhuri G, Sikora SS, Landt O, Kage A, Becker M, Witt H 2002 Tropical calcific pancreatitis: strong association with SPINK1 trypsin inhibitor mutations.
Gastroenterology 123: 1020-1025.
*
-
Bhatia V, Viswanathan P 2006 Insulin resistance and PPAR insulin sensitizers.
Curr. Opin. Investig. Drugs 7: 891-897.
-
Bhatt DL, Chew DP, Grines C, Mukherjee D, Leesar M, Gilchrist IC, Corbelli JC, Blankenship JC, Eres A, Steinhubl S, Tan WA, Resar JR, Almahameed A, Abdel-Latif A, Tang HW, Brennan D, McErlean E, Hazen SL, Topol EJ 2007 Peroxisome proliferator-activated receptor gamma agonists for the prevention of adverse events following percutaneous coronary revascularization - results of the PPAR study.
Am. Heart J. 154: 137-143.
*
-
Bhibhatbhan A, Kline G, Vincent A, Toth C 2007 Anti-MuSK myasthenia gravis presenting with Epstein-Barr virus-associated mononucleosis and immune-mediated diabetes mellitus.
Muscle Nerve 36: 264-266.
-
Bi EG, Shi W, Zou J, Hao ZH, Li ZH, Cai D, Zhang HQ, Sun B 2006 IL-12p40 is not required for islet allograft rejection.
Acta Pharmacol. Sin. 27: 1065-1070.
*
-
Bi Y, Sun WP, Chen X, Li M, Liang H, Cai MY, Zhu YH, He XY, Xu F, Weng JP 2008 Effect of early insulin therapy on nuclear factor kappaB and cytokine gene expressions in the liver and skeletal muscle of high-fat diet, streptozotocin-treated diabetic rats.
Acta Diabetol. 45: 167-178.
-
Biagi F, Campanella J, Soriani A, Vailati A, Corazza GR 2006 Prevalence of coeliac disease in Italian patients affected by Addison's disease.
Scand. J. Gastroenterol. 41: 302-305.
*
-
Biason-Lauber A, Boehm B, Lang-Muritano M, Gauthier BR, Brun T, Wollheim CB, Schoenle EJ 2005 Association of childhood type 1 diabetes mellitus with a variant of PAX4: possible link to beta cell regenerative capacity.
Diabetologia 48: 900-905.
*
-
Bichet DG 2008 Vasopressin receptor mutations in nephrogenic diabetes insipidus.
Semin. Nephrol. 28: 245-251.
-
Bid HK, Konwar R, Agrawal CG, Banerjee M 2008 Association of IL-4 and IL-1RN (receptor antagonist) gene variants and the risk of type 2 diabetes mellitus: a study in the north Indian population.
Indian J. Med. Sci. 62: 259-266.
*
-
Bidel S, Silventoinen K, Hu G, Lee DH, Kaprio J, Tuomilehto J 2008 Coffee consumption, serum gamma-glutamyltransferase and risk of type II diabetes.
Eur. J. Clin. Nutr. 62: 178-185.
*
-
Bieda K, Pani MA, van der Auwera B, Seidl C, Tonjes RR, Gorus F, Usadel KH, Badenhoop K 2002 A retroviral long terminal repeat adjacent to the HLA DQB1 gene (DQ-LTR13) modifies type I diabetes susceptibility on high risk DQ haplotypes.
Diabetologia 45: 443-447.
*
-
Bielinski SJ, Pankow JS, Boerwinkle E, Bray MS, Kao WH, Folsom AR 2008 Lack of association between uncoupling protein-2 Ala55Val polymorphism and incident diabetes in the atherosclerosis risk in communities study.
Acta Diabetol. 45: 179-182.
-
Bierhaus A, Humpert PM, Morcos M, Wendt T, Chavakis T, Arnold B, Stern DM, Nawroth PP 2005 Understanding RAGE, the receptor for advanced glycation end products.
J. Mol. Med. 83: 876-886.
*
-
Bierhaus A, Humpert PM, Stern DM, Arnold B, Nawroth PP 2005 Advanced glycation end product receptor-mediated cellular dysfunction.
Ann. N. Y. Acad. Sci. 1043: 676-680.
-
Biering H, Bohner G, Strasburger CJ 2005 Autoimmune hypophysitis.
Dtsch. Med. Wochenschr. 130: 2826-2828.
-
Biernacka JM, Cordell HJ 2007 Exploring causality via identification of SNPs or haplotypes responsible for a linkage signal.
Genet. Epidemiol. 31: 727-740.
-
Biernacka JM, Sun L, Bull SB 2004 Simultaneous localization of two linked disease susceptibility genes.
Genet. Epidemiol. 28: 33-47.
*
-
Biggins SW, Kim WR, Terrault NA, Saab S, Balan V, Schiano T, Benson J, Therneau T, Kremers W, Wiesner R, Kamath P, Klintmalm G 2006 Evidence-based incorporation of serum sodium concentration into MELD.
Gastroenterology 130: 1652-1660.
*
-
Bilbao JR, Calvo B, Aransay AM, Martin-Pagola A, Perez de Nanclares G, Aly TA, Rica I, Vitoria JC, Gaztambide S, Noble J, Fain PR, Awdeh ZL, Alper CA, Castano L 2006 Conserved extended haplotypes discriminate HLA-DR3-homozygous Basque patients with type 1 diabetes mellitus and celiac disease.
Genes Immun. 7: 550-554.
*
-
Bilbao JR, Martin-Pagola A, Calvo B, Perez de Nanclares G, Gepv-N, Castano L 2002 Contribution of MIC-A polymorphism to type 1 diabetes mellitus in Basques.
Ann. N. Y. Acad. Sci. 958: 321-324.
-
Bilbao JR, Martin-Pagola A, Perez De Nanclares G, Calvo B, Vitoria JC, Vazquez F, Castano L 2003 HLA-DRB1 and MICA in autoimmunity: common associated alleles in autoimmune disorders.
Ann. N. Y. Acad. Sci. 1005: 314-318.
-
Bilbao JR, Martin-Pagola A, Vitoria JC, Zubillaga P, Ortiz L, Castano L 2002 HLA-DRB1 and MHC class 1 chain-related A haplotypes in Basque families with celiac disease.
Tissue Antigens 60: 71-76.
*
-
Bilbao JR, Villoslada P, Martin-Pagola A, Castano L 2004 No evidence of pancreatic autoimmunity among patients with multiple sclerosis.
Ann. N. Y. Acad. Sci. 1037: 133-137.
-
Bilgic S, Aktas E, Salman F, Ersahin G, Erten G, Yilmaz MT, Deniz G 2008 Intracytoplasmic cytokine levels and neutrophil functions in early clinical stage of type 1 diabetes.
Diabetes Res. Clin. Pract. 79: 31-36.
-
Billotey C, Aspord C, Beuf O, Piaggio E, Gazeau F, Janier MF, Thivolet C 2005 T-cell homing to the pancreas in autoimmune mouse models of diabetes: in vivo MR imaging.
Radiology 236: 579-587.
*
-
Bilz S, Samuel V, Morino K, Savage D, Choi CS, Shulman GI 2006 Activation of the farnesoid X receptor improves lipid metabolism in combined hyperlipidemic hamsters.
Am. J. Physiol. Endocrinol. Metab. 290: E716-E722.
*
-
Binstadt BA, Patel PR, Alencar H, Nigrovic PA, Lee DM, Mahmood U, Weissleder R, Mathis D, Benoist C 2006 Particularities of the vasculature can promote the organ specificity of autoimmune attack.
Nat. Immunol. 7: 284-292.
*
-
Bircan R, Miehle K, Mladenova G, Ivanova R, Ivanova R, Sarafova A, Borissova AM, Lublinghoff J, Paschke R 2008 Multiple relapses of hyperthyroidism after thyroid surgeries in a patient with long term follow-up of sporadic non-autoimmune hyperthyroidism.
Exp. Clin. Endocrinol. Diabetes 116: 341-346.
-
Birlea S, Birlea M, Cimponeriu D, Apostol P, Cosgarea R, Gavrila L, Tigan S, Costin G, Das PK 2006 Autoimmune diseases and vitamin D receptor Apa-I polymorphism are associated with vitiligo in a small inbred Romanian community.
Acta Derm. Venereol. 86: 209-214.
*
-
Birlea SA, Costin GE, Norris DA 2008 Cellular and molecular mechanisms involved in the action of vitamin D analogs targeting vitiligo depigmentation.
Curr. Drug Targets 9: 345-359.
-
Birlea SA, Fain PR, Spritz RA 2008 A Romanian population isolate with high frequency of vitiligo and associated autoimmune diseases.
Arch. Dermatol. 144: 310-316.
*
-
Biros E, Jordan MA, Baxter AG 2005 Genes mediating environment interactions in type 1 diabetes.
Rev. Diabet. Stud. 2: 192-207.
*
-
Biscetti F, Gaetani E, Flex A, Tamar A, Hopkins T, Straface G, Pecorini G, Stigliano E, Smith RC, Angelini F, Castellot JJ Jr, Pola R 2008 Selective activation of peroxisome proliferator-activated receptor (PPAR)alpha and PPAR gamma induces neoangiogenesis through a vascular endothelial growth factor-dependent mechanism.
Diabetes 57: 1394-1404.
-
Bishop-Bailey D, Wray J 2003 Peroxisome proliferator-activated receptors: a critical review on endogenous pathways for ligand generation.
Prostaglandins Other Lipid Mediat. 71: 1-22.
-
Bismuth E, Laborde K, Taupin P, Velho G, Ribault V, Jennane F, Grasset E, Sermet I, de Blic J, Lenoir G, Robert JJ 2008 Glucose tolerance and insulin secretion, morbidity, and death in patients with cystic fibrosis.
J. Pediatr. 152: 540-545.e1.
*
-
Bismuth M, Aguilar-Martinez P, Michel H 2003 Hereditary haemochromatosis.
Presse. Med. 32: 1716-1723.
-
Bister V, Kolho KL, Karikoski R, Westerholm-Ormio M, Savilahti E, Saarialho-Kere U 2005 Metalloelastase (MMP-12) is upregulated in the gut of pediatric patients with potential celiac disease and in type 1 diabetes.
Scand. J. Gastroenterol. 40: 1413-1422.
*
-
Biswas A, Chittari K, Gey van Pittius D, Stephens M, Tan BB 2008 Palisaded neutrophilic and granulomatous dermatitis in a child with type I diabetes mellitus and coeliac disease.
Br. J. Dermatol. 159: 488-489.
*
-
Bitan M, Weiss L, Zeira M, Reich S, Pappo O, Vlodavsky I, Slavin S 2008 Heparanase prevents the development of type 1 diabetes in non-obese diabetic mice by regulating T-cell activation and cytokines production.
Diabetes Metab. Res. Rev. 24: 413-421.
-
Bizzaro N 2007 The predictive significance of autoantibodies in organ-specific autoimmune diseases.
Clin. Rev. Allergy Immunol. 34: 326-331.
-
Bjelakovic G, Beninati S, Pavlovic D, Kocic G, Jevtovic T, Kamenov B, Saranac LJ, Bjelakovic B, Stojanovic I, Banic J 2007 Glucocorticoids and oxidative stress.
J. Basic Clin. Physiol. Pharmacol. 18: 115-127.
-
Bjorksten B 2008 Environmental influences on the development of the immune system: consequences for disease outcome.
Nestle Nutr. Workshop Ser. Pediatr. Program. 61: 243-254.
-
Bjornvold M, Amundsen SS, Stene LC, Joner G, Dahl-Jorgensen K, Njolstad PR, Ek J, Ascher H, Gudjonsdottir AH, Lie BA, Skinningsrud B, Akselsen HE, Ronningen KS, Sollid LM, Undlien DE 2006 FOXP3 polymorphisms in type 1 diabetes and coeliac disease.
J. Autoimmun. 27: 140-144.
-
Bjornvold M, Undlien DE, Joner G, Dahl-Jorgensen K, Njolstad PR, Akselsen HE, Gervin K, Ronningen KS, Stene LC 2008 Joint effects of HLA, INS, PTPN22 and CTLA4 genes on the risk of type 1 diabetes.
Diabetologia 51: 589-596.
*
-
Black PH 2006 The inflammatory consequences of psychologic stress: relationship to insulin resistance, obesity, atherosclerosis and diabetes mellitus, type II.
Med. Hypotheses 67: 879-891.
-
Blackwell JM, Searle S 1999 Genetic regulation of macrophage activation: understanding the function of Nramp1 (=Ity/Lsh/Bcg).
Immunol. Lett. 65: 73-80.
-
Blagosklonny MV 2006 Aging and immortality: quasi-programmed senescence and its pharmacologic inhibition.
Cell Cycle 5: 2087-2102.
*
-
Blandino-Rosano M, Perez-Arana G, Mellado-Gil J, Segundo C, Aguilar-Diosdado M 2008 Anti-proliferative effect of pro-inflammatory cytokines in cultured beta cells is associated with Erk1/2 pathway inhibition: protective role of GLP-1.
J. Mol. Endocrinol. 41: 35-44.
*
-
Blankenhorn EP, Descipio C, Rodemich L, Cort L, Leif JH, Greiner DL, Mordes JP 2007 Refinement of the Iddm4 diabetes susceptibility locus reveals TCRVbeta4 as a candidate gene.
Ann. N. Y. Acad. Sci. 1103: 128-131.
-
Blankenhorn EP, Rodemich L, Martin-Fernandez C, Leif J, Greiner DL, Mordes JP 2005 The rat diabetes susceptibility locus iddm4 and at least one additional gene are required for autoimmune diabetes induced by viral infection.
Diabetes 54: 1233-1237.
*
-
Blaschke F, Caglayan E, Hsueh WA 2006 Peroxisome proliferator-activated receptor gamma agonists: their role as vasoprotective agents in diabetes.
Endocrinol. Metab. Clin. North Am. 35: 561-574.
-
Blaschke F, Spanheimer R, Khan M, Law RE 2006 Vascular effects of TZDs: new implications.
Vascul. Pharmacol. 45: 3-18.
-
Blaschke F, Takata Y, Caglayan E, Collins A, Tontonoz P, Hsueh WA, Tangirala RK 2006 A nuclear receptor corepressor-dependent pathway mediates suppression of cytokine-induced C-reactive protein gene expression by liver X receptor.
Circ. Res. 99: e88-e99.
*
-
| |
